company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Anika Therapeutics Inc,ANIK,,0000898437,2010.0,Q2,2010-04-01,2010-06-30,2011-08-10 16:26:04+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,14499800.0
Anika Therapeutics Inc,ANIK,,0000898437,2010.0,Q2,2010-04-01,2010-06-30,2011-08-10 16:26:04+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,14499800.0
Anika Therapeutics Inc,ANIK,,0000898437,2010.0,Q2,2010-04-01,2010-06-30,2011-08-10 16:26:04+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,5891752.0
Anika Therapeutics Inc,ANIK,,0000898437,2010.0,Q2,2010-04-01,2010-06-30,2011-08-10 16:26:04+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,5891752.0
Anika Therapeutics Inc,ANIK,,0000898437,2010.0,Q2,2010-04-01,2010-06-30,2011-08-10 16:26:04+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,8608048.0
Anika Therapeutics Inc,ANIK,,0000898437,2010.0,Q2,2010-04-01,2010-06-30,2011-08-10 16:26:04+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4967346.0
Anika Therapeutics Inc,ANIK,,0000898437,2010.0,Q2,2010-04-01,2010-06-30,2011-08-10 16:26:04+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1836653.0
Anika Therapeutics Inc,ANIK,,0000898437,2010.0,Q2,2010-04-01,2010-06-30,2011-08-10 16:26:04+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6803999.0
Anika Therapeutics Inc,ANIK,,0000898437,2010.0,Q2,2010-04-01,2010-06-30,2011-08-10 16:26:04+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1804049.0
Anika Therapeutics Inc,ANIK,,0000898437,2010.0,Q2,2010-04-01,2010-06-30,2011-08-10 16:26:04+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-59287.0
Anika Therapeutics Inc,ANIK,,0000898437,2010.0,Q2,2010-04-01,2010-06-30,2011-08-10 16:26:04+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-59287.0
Anika Therapeutics Inc,ANIK,,0000898437,2010.0,Q2,2010-04-01,2010-06-30,2011-08-10 16:26:04+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1744762.0
Anika Therapeutics Inc,ANIK,,0000898437,2010.0,Q2,2010-04-01,2010-06-30,2011-08-10 16:26:04+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,678010.0
Anika Therapeutics Inc,ANIK,,0000898437,2010.0,Q2,2010-04-01,2010-06-30,2011-08-10 16:26:04+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1066752.0
Anika Therapeutics Inc,ANIK,,0000898437,2010.0,Q2,2010-04-01,2010-06-30,2011-08-10 16:26:04+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1066752.0
Anika Therapeutics Inc,ANIK,,0000898437,2010.0,Q2,2010-04-01,2010-06-30,2011-08-10 16:26:04+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1066752.0
Anika Therapeutics Inc,ANIK,,0000898437,2010.0,Q2,2010-04-01,2010-06-30,2011-08-10 16:26:04+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,12645889.0
Anika Therapeutics Inc,ANIK,,0000898437,2010.0,Q2,2010-04-01,2010-06-30,2011-08-10 16:26:04+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.08
Anika Therapeutics Inc,ANIK,,0000898437,2010.0,Q2,2010-04-01,2010-06-30,2011-08-10 16:26:04+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,13642323.0
Anika Therapeutics Inc,ANIK,,0000898437,2010.0,Q2,2010-04-01,2010-06-30,2011-08-10 16:26:04+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.08
Anika Therapeutics Inc,ANIK,,0000898437,2010.0,Q2,2010-04-01,2010-06-30,2011-08-10 16:26:04+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,13300000.0
Anika Therapeutics Inc,ANIK,,0000898437,2010.0,Q2,2010-04-01,2010-06-30,2011-08-10 16:26:04+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.08
Anika Therapeutics Inc,ANIK,,0000898437,2010.0,Q3,2010-07-01,2010-09-30,2011-11-04 16:18:07+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,13869214.0
Anika Therapeutics Inc,ANIK,,0000898437,2010.0,Q3,2010-07-01,2010-09-30,2011-11-04 16:18:07+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,13869214.0
Anika Therapeutics Inc,ANIK,,0000898437,2010.0,Q3,2010-07-01,2010-09-30,2011-11-04 16:18:07+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,6108502.0
Anika Therapeutics Inc,ANIK,,0000898437,2010.0,Q3,2010-07-01,2010-09-30,2011-11-04 16:18:07+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,6108502.0
Anika Therapeutics Inc,ANIK,,0000898437,2010.0,Q3,2010-07-01,2010-09-30,2011-11-04 16:18:07+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,7760712.0
Anika Therapeutics Inc,ANIK,,0000898437,2010.0,Q3,2010-07-01,2010-09-30,2011-11-04 16:18:07+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3908452.0
Anika Therapeutics Inc,ANIK,,0000898437,2010.0,Q3,2010-07-01,2010-09-30,2011-11-04 16:18:07+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1774623.0
Anika Therapeutics Inc,ANIK,,0000898437,2010.0,Q3,2010-07-01,2010-09-30,2011-11-04 16:18:07+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5683075.0
Anika Therapeutics Inc,ANIK,,0000898437,2010.0,Q3,2010-07-01,2010-09-30,2011-11-04 16:18:07+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2077637.0
Anika Therapeutics Inc,ANIK,,0000898437,2010.0,Q3,2010-07-01,2010-09-30,2011-11-04 16:18:07+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-39888.0
Anika Therapeutics Inc,ANIK,,0000898437,2010.0,Q3,2010-07-01,2010-09-30,2011-11-04 16:18:07+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-39888.0
Anika Therapeutics Inc,ANIK,,0000898437,2010.0,Q3,2010-07-01,2010-09-30,2011-11-04 16:18:07+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2037749.0
Anika Therapeutics Inc,ANIK,,0000898437,2010.0,Q3,2010-07-01,2010-09-30,2011-11-04 16:18:07+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,853485.0
Anika Therapeutics Inc,ANIK,,0000898437,2010.0,Q3,2010-07-01,2010-09-30,2011-11-04 16:18:07+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1184264.0
Anika Therapeutics Inc,ANIK,,0000898437,2010.0,Q3,2010-07-01,2010-09-30,2011-11-04 16:18:07+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1184264.0
Anika Therapeutics Inc,ANIK,,0000898437,2010.0,Q3,2010-07-01,2010-09-30,2011-11-04 16:18:07+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1184264.0
Anika Therapeutics Inc,ANIK,,0000898437,2010.0,Q3,2010-07-01,2010-09-30,2011-11-04 16:18:07+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,12633405.0
Anika Therapeutics Inc,ANIK,,0000898437,2010.0,Q3,2010-07-01,2010-09-30,2011-11-04 16:18:07+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.09
Anika Therapeutics Inc,ANIK,,0000898437,2010.0,Q3,2010-07-01,2010-09-30,2011-11-04 16:18:07+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,13622603.0
Anika Therapeutics Inc,ANIK,,0000898437,2010.0,Q3,2010-07-01,2010-09-30,2011-11-04 16:18:07+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.09
Anika Therapeutics Inc,ANIK,,0000898437,2010.0,Q3,2010-07-01,2010-09-30,2011-11-04 16:18:07+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,13200000.0
Anika Therapeutics Inc,ANIK,,0000898437,2010.0,Q3,2010-07-01,2010-09-30,2011-11-04 16:18:07+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.09
Anika Therapeutics Inc,ANIK,,0000898437,2011.0,Q1,2011-01-01,2011-03-31,2012-05-07 16:55:49+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,11737679.0
Anika Therapeutics Inc,ANIK,,0000898437,2011.0,Q1,2011-01-01,2011-03-31,2012-05-07 16:55:49+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,11737679.0
Anika Therapeutics Inc,ANIK,,0000898437,2011.0,Q1,2011-01-01,2011-03-31,2012-05-07 16:55:49+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,5604562.0
Anika Therapeutics Inc,ANIK,,0000898437,2011.0,Q1,2011-01-01,2011-03-31,2012-05-07 16:55:49+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,5604562.0
Anika Therapeutics Inc,ANIK,,0000898437,2011.0,Q1,2011-01-01,2011-03-31,2012-05-07 16:55:49+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6133117.0
Anika Therapeutics Inc,ANIK,,0000898437,2011.0,Q1,2011-01-01,2011-03-31,2012-05-07 16:55:49+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4043774.0
Anika Therapeutics Inc,ANIK,,0000898437,2011.0,Q1,2011-01-01,2011-03-31,2012-05-07 16:55:49+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1532664.0
Anika Therapeutics Inc,ANIK,,0000898437,2011.0,Q1,2011-01-01,2011-03-31,2012-05-07 16:55:49+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5576438.0
Anika Therapeutics Inc,ANIK,,0000898437,2011.0,Q1,2011-01-01,2011-03-31,2012-05-07 16:55:49+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,556679.0
Anika Therapeutics Inc,ANIK,,0000898437,2011.0,Q1,2011-01-01,2011-03-31,2012-05-07 16:55:49+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-40921.0
Anika Therapeutics Inc,ANIK,,0000898437,2011.0,Q1,2011-01-01,2011-03-31,2012-05-07 16:55:49+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-40921.0
Anika Therapeutics Inc,ANIK,,0000898437,2011.0,Q1,2011-01-01,2011-03-31,2012-05-07 16:55:49+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,515758.0
Anika Therapeutics Inc,ANIK,,0000898437,2011.0,Q1,2011-01-01,2011-03-31,2012-05-07 16:55:49+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,191346.0
Anika Therapeutics Inc,ANIK,,0000898437,2011.0,Q1,2011-01-01,2011-03-31,2012-05-07 16:55:49+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,324412.0
Anika Therapeutics Inc,ANIK,,0000898437,2011.0,Q1,2011-01-01,2011-03-31,2012-05-07 16:55:49+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,324412.0
Anika Therapeutics Inc,ANIK,,0000898437,2011.0,Q1,2011-01-01,2011-03-31,2012-05-07 16:55:49+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,324412.0
Anika Therapeutics Inc,ANIK,,0000898437,2011.0,Q1,2011-01-01,2011-03-31,2012-05-07 16:55:49+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,12688819.0
Anika Therapeutics Inc,ANIK,,0000898437,2011.0,Q1,2011-01-01,2011-03-31,2012-05-07 16:55:49+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.03
Anika Therapeutics Inc,ANIK,,0000898437,2011.0,Q1,2011-01-01,2011-03-31,2012-05-07 16:55:49+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,13744710.0
Anika Therapeutics Inc,ANIK,,0000898437,2011.0,Q1,2011-01-01,2011-03-31,2012-05-07 16:55:49+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.02
Anika Therapeutics Inc,ANIK,,0000898437,2011.0,Q1,2011-01-01,2011-03-31,2012-05-07 16:55:49+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,10800000.0
Anika Therapeutics Inc,ANIK,,0000898437,2011.0,Q1,2011-01-01,2011-03-31,2012-05-07 16:55:49+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.03
Anika Therapeutics Inc,ANIK,,0000898437,2011.0,Q2,2011-04-01,2011-06-30,2011-08-10 16:26:04+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,16140852.0
Anika Therapeutics Inc,ANIK,,0000898437,2011.0,Q2,2011-04-01,2011-06-30,2011-08-10 16:26:04+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,16140852.0
Anika Therapeutics Inc,ANIK,,0000898437,2011.0,Q2,2011-04-01,2011-06-30,2011-08-10 16:26:04+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,6655804.0
Anika Therapeutics Inc,ANIK,,0000898437,2011.0,Q2,2011-04-01,2011-06-30,2011-08-10 16:26:04+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,6655804.0
Anika Therapeutics Inc,ANIK,,0000898437,2011.0,Q2,2011-04-01,2011-06-30,2011-08-10 16:26:04+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,9485048.0
Anika Therapeutics Inc,ANIK,,0000898437,2011.0,Q2,2011-04-01,2011-06-30,2011-08-10 16:26:04+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4233316.0
Anika Therapeutics Inc,ANIK,,0000898437,2011.0,Q2,2011-04-01,2011-06-30,2011-08-10 16:26:04+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1574155.0
Anika Therapeutics Inc,ANIK,,0000898437,2011.0,Q2,2011-04-01,2011-06-30,2011-08-10 16:26:04+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5807471.0
Anika Therapeutics Inc,ANIK,,0000898437,2011.0,Q2,2011-04-01,2011-06-30,2011-08-10 16:26:04+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3677577.0
Anika Therapeutics Inc,ANIK,,0000898437,2011.0,Q2,2011-04-01,2011-06-30,2011-08-10 16:26:04+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-45281.0
Anika Therapeutics Inc,ANIK,,0000898437,2011.0,Q2,2011-04-01,2011-06-30,2011-08-10 16:26:04+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-45281.0
Anika Therapeutics Inc,ANIK,,0000898437,2011.0,Q2,2011-04-01,2011-06-30,2011-08-10 16:26:04+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3632296.0
Anika Therapeutics Inc,ANIK,,0000898437,2011.0,Q2,2011-04-01,2011-06-30,2011-08-10 16:26:04+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1349655.0
Anika Therapeutics Inc,ANIK,,0000898437,2011.0,Q2,2011-04-01,2011-06-30,2011-08-10 16:26:04+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2282641.0
Anika Therapeutics Inc,ANIK,,0000898437,2011.0,Q2,2011-04-01,2011-06-30,2011-08-10 16:26:04+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2282641.0
Anika Therapeutics Inc,ANIK,,0000898437,2011.0,Q2,2011-04-01,2011-06-30,2011-08-10 16:26:04+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2282641.0
Anika Therapeutics Inc,ANIK,,0000898437,2011.0,Q2,2011-04-01,2011-06-30,2011-08-10 16:26:04+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,12725216.0
Anika Therapeutics Inc,ANIK,,0000898437,2011.0,Q2,2011-04-01,2011-06-30,2011-08-10 16:26:04+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.18
Anika Therapeutics Inc,ANIK,,0000898437,2011.0,Q2,2011-04-01,2011-06-30,2011-08-10 16:26:04+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,13739836.0
Anika Therapeutics Inc,ANIK,,0000898437,2011.0,Q2,2011-04-01,2011-06-30,2011-08-10 16:26:04+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.17
Anika Therapeutics Inc,ANIK,,0000898437,2011.0,Q2,2011-04-01,2011-06-30,2011-08-10 16:26:04+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,12700000.0
Anika Therapeutics Inc,ANIK,,0000898437,2011.0,Q2,2011-04-01,2011-06-30,2011-08-10 16:26:04+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.18
Anika Therapeutics Inc,ANIK,,0000898437,2011.0,Q3,2011-07-01,2011-09-30,2011-11-04 16:18:07+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,18455817.0
Anika Therapeutics Inc,ANIK,,0000898437,2011.0,Q3,2011-07-01,2011-09-30,2011-11-04 16:18:07+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,18455817.0
Anika Therapeutics Inc,ANIK,,0000898437,2011.0,Q3,2011-07-01,2011-09-30,2011-11-04 16:18:07+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,7394922.0
Anika Therapeutics Inc,ANIK,,0000898437,2011.0,Q3,2011-07-01,2011-09-30,2011-11-04 16:18:07+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,7394922.0
Anika Therapeutics Inc,ANIK,,0000898437,2011.0,Q3,2011-07-01,2011-09-30,2011-11-04 16:18:07+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,11060895.0
Anika Therapeutics Inc,ANIK,,0000898437,2011.0,Q3,2011-07-01,2011-09-30,2011-11-04 16:18:07+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4712178.0
Anika Therapeutics Inc,ANIK,,0000898437,2011.0,Q3,2011-07-01,2011-09-30,2011-11-04 16:18:07+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1531355.0
Anika Therapeutics Inc,ANIK,,0000898437,2011.0,Q3,2011-07-01,2011-09-30,2011-11-04 16:18:07+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6243533.0
Anika Therapeutics Inc,ANIK,,0000898437,2011.0,Q3,2011-07-01,2011-09-30,2011-11-04 16:18:07+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,4817362.0
Anika Therapeutics Inc,ANIK,,0000898437,2011.0,Q3,2011-07-01,2011-09-30,2011-11-04 16:18:07+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-46269.0
Anika Therapeutics Inc,ANIK,,0000898437,2011.0,Q3,2011-07-01,2011-09-30,2011-11-04 16:18:07+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-46269.0
Anika Therapeutics Inc,ANIK,,0000898437,2011.0,Q3,2011-07-01,2011-09-30,2011-11-04 16:18:07+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,4771093.0
Anika Therapeutics Inc,ANIK,,0000898437,2011.0,Q3,2011-07-01,2011-09-30,2011-11-04 16:18:07+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1794575.0
Anika Therapeutics Inc,ANIK,,0000898437,2011.0,Q3,2011-07-01,2011-09-30,2011-11-04 16:18:07+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2976518.0
Anika Therapeutics Inc,ANIK,,0000898437,2011.0,Q3,2011-07-01,2011-09-30,2011-11-04 16:18:07+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2976518.0
Anika Therapeutics Inc,ANIK,,0000898437,2011.0,Q3,2011-07-01,2011-09-30,2011-11-04 16:18:07+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2976518.0
Anika Therapeutics Inc,ANIK,,0000898437,2011.0,Q3,2011-07-01,2011-09-30,2011-11-04 16:18:07+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,12817910.0
Anika Therapeutics Inc,ANIK,,0000898437,2011.0,Q3,2011-07-01,2011-09-30,2011-11-04 16:18:07+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.23
Anika Therapeutics Inc,ANIK,,0000898437,2011.0,Q3,2011-07-01,2011-09-30,2011-11-04 16:18:07+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,13765533.0
Anika Therapeutics Inc,ANIK,,0000898437,2011.0,Q3,2011-07-01,2011-09-30,2011-11-04 16:18:07+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.22
Anika Therapeutics Inc,ANIK,,0000898437,2011.0,Q3,2011-07-01,2011-09-30,2011-11-04 16:18:07+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,12900000.0
Anika Therapeutics Inc,ANIK,,0000898437,2011.0,Q3,2011-07-01,2011-09-30,2011-11-04 16:18:07+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.23
Anika Therapeutics Inc,ANIK,,0000898437,2011.0,Q4,2011-10-01,2011-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,18444287.0
Anika Therapeutics Inc,ANIK,,0000898437,2011.0,Q4,2011-10-01,2011-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,18444287.0
Anika Therapeutics Inc,ANIK,,0000898437,2011.0,Q4,2011-10-01,2011-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,7128450.0
Anika Therapeutics Inc,ANIK,,0000898437,2011.0,Q4,2011-10-01,2011-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,7128450.0
Anika Therapeutics Inc,ANIK,,0000898437,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,11315837.0
Anika Therapeutics Inc,ANIK,,0000898437,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4869290.0
Anika Therapeutics Inc,ANIK,,0000898437,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1530763.0
Anika Therapeutics Inc,ANIK,,0000898437,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6400053.0
Anika Therapeutics Inc,ANIK,,0000898437,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,4915784.0
Anika Therapeutics Inc,ANIK,,0000898437,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-49917.0
Anika Therapeutics Inc,ANIK,,0000898437,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-49917.0
Anika Therapeutics Inc,ANIK,,0000898437,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,4865867.0
Anika Therapeutics Inc,ANIK,,0000898437,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1982758.0
Anika Therapeutics Inc,ANIK,,0000898437,2011.0,Q4,2011-10-01,2011-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2883109.0
Anika Therapeutics Inc,ANIK,,0000898437,2011.0,Q4,2011-10-01,2011-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2883109.0
Anika Therapeutics Inc,ANIK,,0000898437,2011.0,Q4,2011-10-01,2011-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2883109.0
Anika Therapeutics Inc,ANIK,,0000898437,2011.0,Q4,2011-10-01,2011-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,13064051.0
Anika Therapeutics Inc,ANIK,,0000898437,2011.0,Q4,2011-10-01,2011-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.21
Anika Therapeutics Inc,ANIK,,0000898437,2011.0,Q4,2011-10-01,2011-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,13747813.0
Anika Therapeutics Inc,ANIK,,0000898437,2011.0,Q4,2011-10-01,2011-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.21
Anika Therapeutics Inc,ANIK,,0000898437,2011.0,Q4,2011-10-01,2011-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,13000000.0
Anika Therapeutics Inc,ANIK,,0000898437,2011.0,Q4,2011-10-01,2011-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.21
Anika Therapeutics Inc,ANIK,,0000898437,2012.0,Q1,2012-01-01,2012-03-31,2012-05-07 16:55:49+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,14360660.0
Anika Therapeutics Inc,ANIK,,0000898437,2012.0,Q1,2012-01-01,2012-03-31,2012-05-07 16:55:49+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,14360660.0
Anika Therapeutics Inc,ANIK,,0000898437,2012.0,Q1,2012-01-01,2012-03-31,2012-05-07 16:55:49+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,6413481.0
Anika Therapeutics Inc,ANIK,,0000898437,2012.0,Q1,2012-01-01,2012-03-31,2012-05-07 16:55:49+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,6413481.0
Anika Therapeutics Inc,ANIK,,0000898437,2012.0,Q1,2012-01-01,2012-03-31,2012-05-07 16:55:49+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,7947179.0
Anika Therapeutics Inc,ANIK,,0000898437,2012.0,Q1,2012-01-01,2012-03-31,2012-05-07 16:55:49+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3351016.0
Anika Therapeutics Inc,ANIK,,0000898437,2012.0,Q1,2012-01-01,2012-03-31,2012-05-07 16:55:49+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1533103.0
Anika Therapeutics Inc,ANIK,,0000898437,2012.0,Q1,2012-01-01,2012-03-31,2012-05-07 16:55:49+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4884119.0
Anika Therapeutics Inc,ANIK,,0000898437,2012.0,Q1,2012-01-01,2012-03-31,2012-05-07 16:55:49+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3063060.0
Anika Therapeutics Inc,ANIK,,0000898437,2012.0,Q1,2012-01-01,2012-03-31,2012-05-07 16:55:49+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-51203.0
Anika Therapeutics Inc,ANIK,,0000898437,2012.0,Q1,2012-01-01,2012-03-31,2012-05-07 16:55:49+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-51203.0
Anika Therapeutics Inc,ANIK,,0000898437,2012.0,Q1,2012-01-01,2012-03-31,2012-05-07 16:55:49+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3011857.0
Anika Therapeutics Inc,ANIK,,0000898437,2012.0,Q1,2012-01-01,2012-03-31,2012-05-07 16:55:49+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1099738.0
Anika Therapeutics Inc,ANIK,,0000898437,2012.0,Q1,2012-01-01,2012-03-31,2012-05-07 16:55:49+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1912119.0
Anika Therapeutics Inc,ANIK,,0000898437,2012.0,Q1,2012-01-01,2012-03-31,2012-05-07 16:55:49+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1912119.0
Anika Therapeutics Inc,ANIK,,0000898437,2012.0,Q1,2012-01-01,2012-03-31,2012-05-07 16:55:49+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1912119.0
Anika Therapeutics Inc,ANIK,,0000898437,2012.0,Q1,2012-01-01,2012-03-31,2012-05-07 16:55:49+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,13162824.0
Anika Therapeutics Inc,ANIK,,0000898437,2012.0,Q1,2012-01-01,2012-03-31,2012-05-07 16:55:49+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.15
Anika Therapeutics Inc,ANIK,,0000898437,2012.0,Q1,2012-01-01,2012-03-31,2012-05-07 16:55:49+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,14089946.0
Anika Therapeutics Inc,ANIK,,0000898437,2012.0,Q1,2012-01-01,2012-03-31,2012-05-07 16:55:49+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.14
Anika Therapeutics Inc,ANIK,,0000898437,2012.0,Q1,2012-01-01,2012-03-31,2012-05-07 16:55:49+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,12700000.0
Anika Therapeutics Inc,ANIK,,0000898437,2012.0,Q1,2012-01-01,2012-03-31,2012-05-07 16:55:49+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.15
Anika Therapeutics Inc,ANIK,,0000898437,2012.0,Q2,2012-04-01,2012-06-30,2012-08-07 16:07:47+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,19624769.0
Anika Therapeutics Inc,ANIK,,0000898437,2012.0,Q2,2012-04-01,2012-06-30,2012-08-07 16:07:47+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,19624769.0
Anika Therapeutics Inc,ANIK,,0000898437,2012.0,Q2,2012-04-01,2012-06-30,2012-08-07 16:07:47+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,8084226.0
Anika Therapeutics Inc,ANIK,,0000898437,2012.0,Q2,2012-04-01,2012-06-30,2012-08-07 16:07:47+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,8084226.0
Anika Therapeutics Inc,ANIK,,0000898437,2012.0,Q2,2012-04-01,2012-06-30,2012-08-07 16:07:47+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,11540543.0
Anika Therapeutics Inc,ANIK,,0000898437,2012.0,Q2,2012-04-01,2012-06-30,2012-08-07 16:07:47+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4108503.0
Anika Therapeutics Inc,ANIK,,0000898437,2012.0,Q2,2012-04-01,2012-06-30,2012-08-07 16:07:47+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1298170.0
Anika Therapeutics Inc,ANIK,,0000898437,2012.0,Q2,2012-04-01,2012-06-30,2012-08-07 16:07:47+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5406673.0
Anika Therapeutics Inc,ANIK,,0000898437,2012.0,Q2,2012-04-01,2012-06-30,2012-08-07 16:07:47+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,6133870.0
Anika Therapeutics Inc,ANIK,,0000898437,2012.0,Q2,2012-04-01,2012-06-30,2012-08-07 16:07:47+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-49129.0
Anika Therapeutics Inc,ANIK,,0000898437,2012.0,Q2,2012-04-01,2012-06-30,2012-08-07 16:07:47+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-49129.0
Anika Therapeutics Inc,ANIK,,0000898437,2012.0,Q2,2012-04-01,2012-06-30,2012-08-07 16:07:47+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,6084741.0
Anika Therapeutics Inc,ANIK,,0000898437,2012.0,Q2,2012-04-01,2012-06-30,2012-08-07 16:07:47+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,2347873.0
Anika Therapeutics Inc,ANIK,,0000898437,2012.0,Q2,2012-04-01,2012-06-30,2012-08-07 16:07:47+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3736868.0
Anika Therapeutics Inc,ANIK,,0000898437,2012.0,Q2,2012-04-01,2012-06-30,2012-08-07 16:07:47+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3736868.0
Anika Therapeutics Inc,ANIK,,0000898437,2012.0,Q2,2012-04-01,2012-06-30,2012-08-07 16:07:47+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3736868.0
Anika Therapeutics Inc,ANIK,,0000898437,2012.0,Q2,2012-04-01,2012-06-30,2012-08-07 16:07:47+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,13262023.0
Anika Therapeutics Inc,ANIK,,0000898437,2012.0,Q2,2012-04-01,2012-06-30,2012-08-07 16:07:47+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.28
Anika Therapeutics Inc,ANIK,,0000898437,2012.0,Q2,2012-04-01,2012-06-30,2012-08-07 16:07:47+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,14443794.0
Anika Therapeutics Inc,ANIK,,0000898437,2012.0,Q2,2012-04-01,2012-06-30,2012-08-07 16:07:47+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.26
Anika Therapeutics Inc,ANIK,,0000898437,2012.0,Q2,2012-04-01,2012-06-30,2012-08-07 16:07:47+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,13300000.0
Anika Therapeutics Inc,ANIK,,0000898437,2012.0,Q2,2012-04-01,2012-06-30,2012-08-07 16:07:47+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.28
Anika Therapeutics Inc,ANIK,,0000898437,2012.0,Q3,2012-07-01,2012-09-30,2012-11-08 15:40:18+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,14766611.0
Anika Therapeutics Inc,ANIK,,0000898437,2012.0,Q3,2012-07-01,2012-09-30,2012-11-08 15:40:18+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,14766611.0
Anika Therapeutics Inc,ANIK,,0000898437,2012.0,Q3,2012-07-01,2012-09-30,2012-11-08 15:40:18+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,7221028.0
Anika Therapeutics Inc,ANIK,,0000898437,2012.0,Q3,2012-07-01,2012-09-30,2012-11-08 15:40:18+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,7221028.0
Anika Therapeutics Inc,ANIK,,0000898437,2012.0,Q3,2012-07-01,2012-09-30,2012-11-08 15:40:18+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,7545583.0
Anika Therapeutics Inc,ANIK,,0000898437,2012.0,Q3,2012-07-01,2012-09-30,2012-11-08 15:40:18+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3601737.0
Anika Therapeutics Inc,ANIK,,0000898437,2012.0,Q3,2012-07-01,2012-09-30,2012-11-08 15:40:18+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1217086.0
Anika Therapeutics Inc,ANIK,,0000898437,2012.0,Q3,2012-07-01,2012-09-30,2012-11-08 15:40:18+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4818823.0
Anika Therapeutics Inc,ANIK,,0000898437,2012.0,Q3,2012-07-01,2012-09-30,2012-11-08 15:40:18+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2726760.0
Anika Therapeutics Inc,ANIK,,0000898437,2012.0,Q3,2012-07-01,2012-09-30,2012-11-08 15:40:18+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-45161.0
Anika Therapeutics Inc,ANIK,,0000898437,2012.0,Q3,2012-07-01,2012-09-30,2012-11-08 15:40:18+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-45161.0
Anika Therapeutics Inc,ANIK,,0000898437,2012.0,Q3,2012-07-01,2012-09-30,2012-11-08 15:40:18+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2681599.0
Anika Therapeutics Inc,ANIK,,0000898437,2012.0,Q3,2012-07-01,2012-09-30,2012-11-08 15:40:18+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1036349.0
Anika Therapeutics Inc,ANIK,,0000898437,2012.0,Q3,2012-07-01,2012-09-30,2012-11-08 15:40:18+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1645250.0
Anika Therapeutics Inc,ANIK,,0000898437,2012.0,Q3,2012-07-01,2012-09-30,2012-11-08 15:40:18+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1645250.0
Anika Therapeutics Inc,ANIK,,0000898437,2012.0,Q3,2012-07-01,2012-09-30,2012-11-08 15:40:18+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1645250.0
Anika Therapeutics Inc,ANIK,,0000898437,2012.0,Q3,2012-07-01,2012-09-30,2012-11-08 15:40:18+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,13287463.0
Anika Therapeutics Inc,ANIK,,0000898437,2012.0,Q3,2012-07-01,2012-09-30,2012-11-08 15:40:18+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.12
Anika Therapeutics Inc,ANIK,,0000898437,2012.0,Q3,2012-07-01,2012-09-30,2012-11-08 15:40:18+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,14459154.0
Anika Therapeutics Inc,ANIK,,0000898437,2012.0,Q3,2012-07-01,2012-09-30,2012-11-08 15:40:18+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.11
Anika Therapeutics Inc,ANIK,,0000898437,2012.0,Q3,2012-07-01,2012-09-30,2012-11-08 15:40:18+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,13700000.0
Anika Therapeutics Inc,ANIK,,0000898437,2012.0,Q3,2012-07-01,2012-09-30,2012-11-08 15:40:18+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.12
Anika Therapeutics Inc,ANIK,,0000898437,2012.0,Q4,2012-10-01,2012-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,22606465.0
Anika Therapeutics Inc,ANIK,,0000898437,2012.0,Q4,2012-10-01,2012-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,22606465.0
Anika Therapeutics Inc,ANIK,,0000898437,2012.0,Q4,2012-10-01,2012-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,7269886.0
Anika Therapeutics Inc,ANIK,,0000898437,2012.0,Q4,2012-10-01,2012-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,7269886.0
Anika Therapeutics Inc,ANIK,,0000898437,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,15336579.0
Anika Therapeutics Inc,ANIK,,0000898437,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3667406.0
Anika Therapeutics Inc,ANIK,,0000898437,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1339677.0
Anika Therapeutics Inc,ANIK,,0000898437,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,2537988.0
Anika Therapeutics Inc,ANIK,,0000898437,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,7545071.0
Anika Therapeutics Inc,ANIK,,0000898437,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,7791508.0
Anika Therapeutics Inc,ANIK,,0000898437,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-42284.0
Anika Therapeutics Inc,ANIK,,0000898437,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-42284.0
Anika Therapeutics Inc,ANIK,,0000898437,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,7749224.0
Anika Therapeutics Inc,ANIK,,0000898437,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,3286001.0
Anika Therapeutics Inc,ANIK,,0000898437,2012.0,Q4,2012-10-01,2012-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4463223.0
Anika Therapeutics Inc,ANIK,,0000898437,2012.0,Q4,2012-10-01,2012-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4463223.0
Anika Therapeutics Inc,ANIK,,0000898437,2012.0,Q4,2012-10-01,2012-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,4463223.0
Anika Therapeutics Inc,ANIK,,0000898437,2012.0,Q4,2012-10-01,2012-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,13260739.0
Anika Therapeutics Inc,ANIK,,0000898437,2012.0,Q4,2012-10-01,2012-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.34
Anika Therapeutics Inc,ANIK,,0000898437,2012.0,Q4,2012-10-01,2012-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,14344577.0
Anika Therapeutics Inc,ANIK,,0000898437,2012.0,Q4,2012-10-01,2012-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.31
Anika Therapeutics Inc,ANIK,,0000898437,2012.0,Q4,2012-10-01,2012-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,13200000.0
Anika Therapeutics Inc,ANIK,,0000898437,2012.0,Q4,2012-10-01,2012-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.34
Anika Therapeutics Inc,ANIK,,0000898437,2013.0,Q1,2013-01-01,2013-03-31,2013-05-06 16:35:10+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,15247011.0
Anika Therapeutics Inc,ANIK,,0000898437,2013.0,Q1,2013-01-01,2013-03-31,2013-05-06 16:35:10+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,15247011.0
Anika Therapeutics Inc,ANIK,,0000898437,2013.0,Q1,2013-01-01,2013-03-31,2013-05-06 16:35:10+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4841170.0
Anika Therapeutics Inc,ANIK,,0000898437,2013.0,Q1,2013-01-01,2013-03-31,2013-05-06 16:35:10+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4841170.0
Anika Therapeutics Inc,ANIK,,0000898437,2013.0,Q1,2013-01-01,2013-03-31,2013-05-06 16:35:10+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,10405841.0
Anika Therapeutics Inc,ANIK,,0000898437,2013.0,Q1,2013-01-01,2013-03-31,2013-05-06 16:35:10+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3947114.0
Anika Therapeutics Inc,ANIK,,0000898437,2013.0,Q1,2013-01-01,2013-03-31,2013-05-06 16:35:10+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1582910.0
Anika Therapeutics Inc,ANIK,,0000898437,2013.0,Q1,2013-01-01,2013-03-31,2013-05-06 16:35:10+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,-135607.0
Anika Therapeutics Inc,ANIK,,0000898437,2013.0,Q1,2013-01-01,2013-03-31,2013-05-06 16:35:10+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5394417.0
Anika Therapeutics Inc,ANIK,,0000898437,2013.0,Q1,2013-01-01,2013-03-31,2013-05-06 16:35:10+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,5011424.0
Anika Therapeutics Inc,ANIK,,0000898437,2013.0,Q1,2013-01-01,2013-03-31,2013-05-06 16:35:10+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-39558.0
Anika Therapeutics Inc,ANIK,,0000898437,2013.0,Q1,2013-01-01,2013-03-31,2013-05-06 16:35:10+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-39558.0
Anika Therapeutics Inc,ANIK,,0000898437,2013.0,Q1,2013-01-01,2013-03-31,2013-05-06 16:35:10+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,4971866.0
Anika Therapeutics Inc,ANIK,,0000898437,2013.0,Q1,2013-01-01,2013-03-31,2013-05-06 16:35:10+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1903864.0
Anika Therapeutics Inc,ANIK,,0000898437,2013.0,Q1,2013-01-01,2013-03-31,2013-05-06 16:35:10+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3068002.0
Anika Therapeutics Inc,ANIK,,0000898437,2013.0,Q1,2013-01-01,2013-03-31,2013-05-06 16:35:10+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3068002.0
Anika Therapeutics Inc,ANIK,,0000898437,2013.0,Q1,2013-01-01,2013-03-31,2013-05-06 16:35:10+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3068002.0
Anika Therapeutics Inc,ANIK,,0000898437,2013.0,Q1,2013-01-01,2013-03-31,2013-05-06 16:35:10+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,13406952.0
Anika Therapeutics Inc,ANIK,,0000898437,2013.0,Q1,2013-01-01,2013-03-31,2013-05-06 16:35:10+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.23
Anika Therapeutics Inc,ANIK,,0000898437,2013.0,Q1,2013-01-01,2013-03-31,2013-05-06 16:35:10+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,14357110.0
Anika Therapeutics Inc,ANIK,,0000898437,2013.0,Q1,2013-01-01,2013-03-31,2013-05-06 16:35:10+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.21
Anika Therapeutics Inc,ANIK,,0000898437,2013.0,Q1,2013-01-01,2013-03-31,2013-05-06 16:35:10+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,13300000.0
Anika Therapeutics Inc,ANIK,,0000898437,2013.0,Q1,2013-01-01,2013-03-31,2013-05-06 16:35:10+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.23
Anika Therapeutics Inc,ANIK,,0000898437,2013.0,Q2,2013-04-01,2013-06-30,2013-08-06 17:19:45+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,20828377.0
Anika Therapeutics Inc,ANIK,,0000898437,2013.0,Q2,2013-04-01,2013-06-30,2013-08-06 17:19:45+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,20828377.0
Anika Therapeutics Inc,ANIK,,0000898437,2013.0,Q2,2013-04-01,2013-06-30,2013-08-06 17:19:45+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,6311332.0
Anika Therapeutics Inc,ANIK,,0000898437,2013.0,Q2,2013-04-01,2013-06-30,2013-08-06 17:19:45+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,6311332.0
Anika Therapeutics Inc,ANIK,,0000898437,2013.0,Q2,2013-04-01,2013-06-30,2013-08-06 17:19:45+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,14517045.0
Anika Therapeutics Inc,ANIK,,0000898437,2013.0,Q2,2013-04-01,2013-06-30,2013-08-06 17:19:45+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3400679.0
Anika Therapeutics Inc,ANIK,,0000898437,2013.0,Q2,2013-04-01,2013-06-30,2013-08-06 17:19:45+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1829052.0
Anika Therapeutics Inc,ANIK,,0000898437,2013.0,Q2,2013-04-01,2013-06-30,2013-08-06 17:19:45+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,-111178.0
Anika Therapeutics Inc,ANIK,,0000898437,2013.0,Q2,2013-04-01,2013-06-30,2013-08-06 17:19:45+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5118553.0
Anika Therapeutics Inc,ANIK,,0000898437,2013.0,Q2,2013-04-01,2013-06-30,2013-08-06 17:19:45+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,9398492.0
Anika Therapeutics Inc,ANIK,,0000898437,2013.0,Q2,2013-04-01,2013-06-30,2013-08-06 17:19:45+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-36381.0
Anika Therapeutics Inc,ANIK,,0000898437,2013.0,Q2,2013-04-01,2013-06-30,2013-08-06 17:19:45+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-36381.0
Anika Therapeutics Inc,ANIK,,0000898437,2013.0,Q2,2013-04-01,2013-06-30,2013-08-06 17:19:45+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,9362111.0
Anika Therapeutics Inc,ANIK,,0000898437,2013.0,Q2,2013-04-01,2013-06-30,2013-08-06 17:19:45+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,3467219.0
Anika Therapeutics Inc,ANIK,,0000898437,2013.0,Q2,2013-04-01,2013-06-30,2013-08-06 17:19:45+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5894892.0
Anika Therapeutics Inc,ANIK,,0000898437,2013.0,Q2,2013-04-01,2013-06-30,2013-08-06 17:19:45+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,5894892.0
Anika Therapeutics Inc,ANIK,,0000898437,2013.0,Q2,2013-04-01,2013-06-30,2013-08-06 17:19:45+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,5894892.0
Anika Therapeutics Inc,ANIK,,0000898437,2013.0,Q2,2013-04-01,2013-06-30,2013-08-06 17:19:45+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,13510573.0
Anika Therapeutics Inc,ANIK,,0000898437,2013.0,Q2,2013-04-01,2013-06-30,2013-08-06 17:19:45+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.44
Anika Therapeutics Inc,ANIK,,0000898437,2013.0,Q2,2013-04-01,2013-06-30,2013-08-06 17:19:45+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,14578927.0
Anika Therapeutics Inc,ANIK,,0000898437,2013.0,Q2,2013-04-01,2013-06-30,2013-08-06 17:19:45+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.4
Anika Therapeutics Inc,ANIK,,0000898437,2013.0,Q2,2013-04-01,2013-06-30,2013-08-06 17:19:45+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,13400000.0
Anika Therapeutics Inc,ANIK,,0000898437,2013.0,Q2,2013-04-01,2013-06-30,2013-08-06 17:19:45+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.44
Anika Therapeutics Inc,ANIK,,0000898437,2013.0,Q3,2013-07-01,2013-09-30,2013-11-05 16:06:10+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,17754438.0
Anika Therapeutics Inc,ANIK,,0000898437,2013.0,Q3,2013-07-01,2013-09-30,2013-11-05 16:06:10+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,17754438.0
Anika Therapeutics Inc,ANIK,,0000898437,2013.0,Q3,2013-07-01,2013-09-30,2013-11-05 16:06:10+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,5377568.0
Anika Therapeutics Inc,ANIK,,0000898437,2013.0,Q3,2013-07-01,2013-09-30,2013-11-05 16:06:10+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,5377568.0
Anika Therapeutics Inc,ANIK,,0000898437,2013.0,Q3,2013-07-01,2013-09-30,2013-11-05 16:06:10+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,12376870.0
Anika Therapeutics Inc,ANIK,,0000898437,2013.0,Q3,2013-07-01,2013-09-30,2013-11-05 16:06:10+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3188669.0
Anika Therapeutics Inc,ANIK,,0000898437,2013.0,Q3,2013-07-01,2013-09-30,2013-11-05 16:06:10+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1618012.0
Anika Therapeutics Inc,ANIK,,0000898437,2013.0,Q3,2013-07-01,2013-09-30,2013-11-05 16:06:10+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,-196084.0
Anika Therapeutics Inc,ANIK,,0000898437,2013.0,Q3,2013-07-01,2013-09-30,2013-11-05 16:06:10+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4610597.0
Anika Therapeutics Inc,ANIK,,0000898437,2013.0,Q3,2013-07-01,2013-09-30,2013-11-05 16:06:10+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,7766273.0
Anika Therapeutics Inc,ANIK,,0000898437,2013.0,Q3,2013-07-01,2013-09-30,2013-11-05 16:06:10+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-32816.0
Anika Therapeutics Inc,ANIK,,0000898437,2013.0,Q3,2013-07-01,2013-09-30,2013-11-05 16:06:10+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-32816.0
Anika Therapeutics Inc,ANIK,,0000898437,2013.0,Q3,2013-07-01,2013-09-30,2013-11-05 16:06:10+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,7733457.0
Anika Therapeutics Inc,ANIK,,0000898437,2013.0,Q3,2013-07-01,2013-09-30,2013-11-05 16:06:10+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,2776199.0
Anika Therapeutics Inc,ANIK,,0000898437,2013.0,Q3,2013-07-01,2013-09-30,2013-11-05 16:06:10+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4957258.0
Anika Therapeutics Inc,ANIK,,0000898437,2013.0,Q3,2013-07-01,2013-09-30,2013-11-05 16:06:10+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4957258.0
Anika Therapeutics Inc,ANIK,,0000898437,2013.0,Q3,2013-07-01,2013-09-30,2013-11-05 16:06:10+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,4957258.0
Anika Therapeutics Inc,ANIK,,0000898437,2013.0,Q3,2013-07-01,2013-09-30,2013-11-05 16:06:10+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,13682449.0
Anika Therapeutics Inc,ANIK,,0000898437,2013.0,Q3,2013-07-01,2013-09-30,2013-11-05 16:06:10+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.36
Anika Therapeutics Inc,ANIK,,0000898437,2013.0,Q3,2013-07-01,2013-09-30,2013-11-05 16:06:10+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,14958965.0
Anika Therapeutics Inc,ANIK,,0000898437,2013.0,Q3,2013-07-01,2013-09-30,2013-11-05 16:06:10+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.33
Anika Therapeutics Inc,ANIK,,0000898437,2013.0,Q3,2013-07-01,2013-09-30,2013-11-05 16:06:10+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,13800000.0
Anika Therapeutics Inc,ANIK,,0000898437,2013.0,Q3,2013-07-01,2013-09-30,2013-11-05 16:06:10+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.36
Anika Therapeutics Inc,ANIK,,0000898437,2013.0,Q4,2013-10-01,2013-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,21251328.0
Anika Therapeutics Inc,ANIK,,0000898437,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,21251328.0
Anika Therapeutics Inc,ANIK,,0000898437,2013.0,Q4,2013-10-01,2013-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,6235334.0
Anika Therapeutics Inc,ANIK,,0000898437,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,6235334.0
Anika Therapeutics Inc,ANIK,,0000898437,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,15015994.0
Anika Therapeutics Inc,ANIK,,0000898437,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2399539.0
Anika Therapeutics Inc,ANIK,,0000898437,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2029901.0
Anika Therapeutics Inc,ANIK,,0000898437,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,156026.0
Anika Therapeutics Inc,ANIK,,0000898437,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4585466.0
Anika Therapeutics Inc,ANIK,,0000898437,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,10430528.0
Anika Therapeutics Inc,ANIK,,0000898437,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-18431.0
Anika Therapeutics Inc,ANIK,,0000898437,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-18431.0
Anika Therapeutics Inc,ANIK,,0000898437,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,10412097.0
Anika Therapeutics Inc,ANIK,,0000898437,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,3757728.0
Anika Therapeutics Inc,ANIK,,0000898437,2013.0,Q4,2013-10-01,2013-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,6654369.0
Anika Therapeutics Inc,ANIK,,0000898437,2013.0,Q4,2013-10-01,2013-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,6654369.0
Anika Therapeutics Inc,ANIK,,0000898437,2013.0,Q4,2013-10-01,2013-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,6654369.0
Anika Therapeutics Inc,ANIK,,0000898437,2013.0,Q4,2013-10-01,2013-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,14086912.0
Anika Therapeutics Inc,ANIK,,0000898437,2013.0,Q4,2013-10-01,2013-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.43
Anika Therapeutics Inc,ANIK,,0000898437,2013.0,Q4,2013-10-01,2013-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,14825599.0
Anika Therapeutics Inc,ANIK,,0000898437,2013.0,Q4,2013-10-01,2013-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.45
Anika Therapeutics Inc,ANIK,,0000898437,2013.0,Q4,2013-10-01,2013-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,14100000.0
Anika Therapeutics Inc,ANIK,,0000898437,2013.0,Q4,2013-10-01,2013-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.43
Anika Therapeutics Inc,ANIK,,0000898437,2014.0,Q1,2014-01-01,2014-03-31,2014-05-05 17:27:31+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,34010287.0
Anika Therapeutics Inc,ANIK,,0000898437,2014.0,Q1,2014-01-01,2014-03-31,2014-05-05 17:27:31+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,34010287.0
Anika Therapeutics Inc,ANIK,,0000898437,2014.0,Q1,2014-01-01,2014-03-31,2014-05-05 17:27:31+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4361019.0
Anika Therapeutics Inc,ANIK,,0000898437,2014.0,Q1,2014-01-01,2014-03-31,2014-05-05 17:27:31+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4361019.0
Anika Therapeutics Inc,ANIK,,0000898437,2014.0,Q1,2014-01-01,2014-03-31,2014-05-05 17:27:31+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,29649268.0
Anika Therapeutics Inc,ANIK,,0000898437,2014.0,Q1,2014-01-01,2014-03-31,2014-05-05 17:27:31+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3490985.0
Anika Therapeutics Inc,ANIK,,0000898437,2014.0,Q1,2014-01-01,2014-03-31,2014-05-05 17:27:31+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2287715.0
Anika Therapeutics Inc,ANIK,,0000898437,2014.0,Q1,2014-01-01,2014-03-31,2014-05-05 17:27:31+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5778700.0
Anika Therapeutics Inc,ANIK,,0000898437,2014.0,Q1,2014-01-01,2014-03-31,2014-05-05 17:27:31+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,23870568.0
Anika Therapeutics Inc,ANIK,,0000898437,2014.0,Q1,2014-01-01,2014-03-31,2014-05-05 17:27:31+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,467.0
Anika Therapeutics Inc,ANIK,,0000898437,2014.0,Q1,2014-01-01,2014-03-31,2014-05-05 17:27:31+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,467.0
Anika Therapeutics Inc,ANIK,,0000898437,2014.0,Q1,2014-01-01,2014-03-31,2014-05-05 17:27:31+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,23871035.0
Anika Therapeutics Inc,ANIK,,0000898437,2014.0,Q1,2014-01-01,2014-03-31,2014-05-05 17:27:31+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,8840782.0
Anika Therapeutics Inc,ANIK,,0000898437,2014.0,Q1,2014-01-01,2014-03-31,2014-05-05 17:27:31+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,15030253.0
Anika Therapeutics Inc,ANIK,,0000898437,2014.0,Q1,2014-01-01,2014-03-31,2014-05-05 17:27:31+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,15030253.0
Anika Therapeutics Inc,ANIK,,0000898437,2014.0,Q1,2014-01-01,2014-03-31,2014-05-05 17:27:31+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,15030253.0
Anika Therapeutics Inc,ANIK,,0000898437,2014.0,Q1,2014-01-01,2014-03-31,2014-05-05 17:27:31+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,14461367.0
Anika Therapeutics Inc,ANIK,,0000898437,2014.0,Q1,2014-01-01,2014-03-31,2014-05-05 17:27:31+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.04
Anika Therapeutics Inc,ANIK,,0000898437,2014.0,Q1,2014-01-01,2014-03-31,2014-05-05 17:27:31+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,15499447.0
Anika Therapeutics Inc,ANIK,,0000898437,2014.0,Q1,2014-01-01,2014-03-31,2014-05-05 17:27:31+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.97
Anika Therapeutics Inc,ANIK,,0000898437,2014.0,Q1,2014-01-01,2014-03-31,2014-05-05 17:27:31+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,14500000.0
Anika Therapeutics Inc,ANIK,,0000898437,2014.0,Q1,2014-01-01,2014-03-31,2014-05-05 17:27:31+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.04
Anika Therapeutics Inc,ANIK,,0000898437,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 16:23:45+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,26274660.0
Anika Therapeutics Inc,ANIK,,0000898437,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 16:23:45+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,26274660.0
Anika Therapeutics Inc,ANIK,,0000898437,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 16:23:45+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,5332913.0
Anika Therapeutics Inc,ANIK,,0000898437,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 16:23:45+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,5332913.0
Anika Therapeutics Inc,ANIK,,0000898437,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 16:23:45+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,20941747.0
Anika Therapeutics Inc,ANIK,,0000898437,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 16:23:45+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3865876.0
Anika Therapeutics Inc,ANIK,,0000898437,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 16:23:45+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1873158.0
Anika Therapeutics Inc,ANIK,,0000898437,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 16:23:45+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5739034.0
Anika Therapeutics Inc,ANIK,,0000898437,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 16:23:45+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,15202713.0
Anika Therapeutics Inc,ANIK,,0000898437,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 16:23:45+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,5935.0
Anika Therapeutics Inc,ANIK,,0000898437,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 16:23:45+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,5935.0
Anika Therapeutics Inc,ANIK,,0000898437,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 16:23:45+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,15208648.0
Anika Therapeutics Inc,ANIK,,0000898437,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 16:23:45+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,5906298.0
Anika Therapeutics Inc,ANIK,,0000898437,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 16:23:45+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,9302350.0
Anika Therapeutics Inc,ANIK,,0000898437,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 16:23:45+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,9302350.0
Anika Therapeutics Inc,ANIK,,0000898437,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 16:23:45+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,9302350.0
Anika Therapeutics Inc,ANIK,,0000898437,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 16:23:45+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,14687747.0
Anika Therapeutics Inc,ANIK,,0000898437,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 16:23:45+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.63
Anika Therapeutics Inc,ANIK,,0000898437,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 16:23:45+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,15492732.0
Anika Therapeutics Inc,ANIK,,0000898437,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 16:23:45+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.6
Anika Therapeutics Inc,ANIK,,0000898437,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 16:23:45+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,14800000.0
Anika Therapeutics Inc,ANIK,,0000898437,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 16:23:45+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.63
Anika Therapeutics Inc,ANIK,,0000898437,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 16:06:13+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,22055423.0
Anika Therapeutics Inc,ANIK,,0000898437,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 16:06:13+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,22055423.0
Anika Therapeutics Inc,ANIK,,0000898437,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 16:06:13+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,5724800.0
Anika Therapeutics Inc,ANIK,,0000898437,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 16:06:13+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,5724800.0
Anika Therapeutics Inc,ANIK,,0000898437,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 16:06:13+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,16330623.0
Anika Therapeutics Inc,ANIK,,0000898437,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 16:06:13+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4044538.0
Anika Therapeutics Inc,ANIK,,0000898437,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 16:06:13+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1999867.0
Anika Therapeutics Inc,ANIK,,0000898437,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 16:06:13+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6044405.0
Anika Therapeutics Inc,ANIK,,0000898437,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 16:06:13+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,10286218.0
Anika Therapeutics Inc,ANIK,,0000898437,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 16:06:13+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,9937.0
Anika Therapeutics Inc,ANIK,,0000898437,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 16:06:13+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,9937.0
Anika Therapeutics Inc,ANIK,,0000898437,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 16:06:13+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,10296155.0
Anika Therapeutics Inc,ANIK,,0000898437,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 16:06:13+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,4125355.0
Anika Therapeutics Inc,ANIK,,0000898437,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 16:06:13+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,6170800.0
Anika Therapeutics Inc,ANIK,,0000898437,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 16:06:13+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,6170800.0
Anika Therapeutics Inc,ANIK,,0000898437,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 16:06:13+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,6170800.0
Anika Therapeutics Inc,ANIK,,0000898437,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 16:06:13+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,14758781.0
Anika Therapeutics Inc,ANIK,,0000898437,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 16:06:13+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.42
Anika Therapeutics Inc,ANIK,,0000898437,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 16:06:13+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,15434875.0
Anika Therapeutics Inc,ANIK,,0000898437,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 16:06:13+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.4
Anika Therapeutics Inc,ANIK,,0000898437,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 16:06:13+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,14700000.0
Anika Therapeutics Inc,ANIK,,0000898437,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 16:06:13+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.42
Anika Therapeutics Inc,ANIK,,0000898437,2014.0,Q4,2014-10-01,2014-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,23254630.0
Anika Therapeutics Inc,ANIK,,0000898437,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,23254630.0
Anika Therapeutics Inc,ANIK,,0000898437,2014.0,Q4,2014-10-01,2014-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,5511268.0
Anika Therapeutics Inc,ANIK,,0000898437,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,5511268.0
Anika Therapeutics Inc,ANIK,,0000898437,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,17743362.0
Anika Therapeutics Inc,ANIK,,0000898437,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3672601.0
Anika Therapeutics Inc,ANIK,,0000898437,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1983260.0
Anika Therapeutics Inc,ANIK,,0000898437,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5655861.0
Anika Therapeutics Inc,ANIK,,0000898437,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,12087501.0
Anika Therapeutics Inc,ANIK,,0000898437,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,41661.0
Anika Therapeutics Inc,ANIK,,0000898437,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,41661.0
Anika Therapeutics Inc,ANIK,,0000898437,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,12129162.0
Anika Therapeutics Inc,ANIK,,0000898437,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,4313565.0
Anika Therapeutics Inc,ANIK,,0000898437,2014.0,Q4,2014-10-01,2014-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,7815597.0
Anika Therapeutics Inc,ANIK,,0000898437,2014.0,Q4,2014-10-01,2014-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,7815597.0
Anika Therapeutics Inc,ANIK,,0000898437,2014.0,Q4,2014-10-01,2014-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,7815597.0
Anika Therapeutics Inc,ANIK,,0000898437,2014.0,Q4,2014-10-01,2014-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,14678000.0
Anika Therapeutics Inc,ANIK,,0000898437,2014.0,Q4,2014-10-01,2014-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.52
Anika Therapeutics Inc,ANIK,,0000898437,2014.0,Q4,2014-10-01,2014-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,15269000.0
Anika Therapeutics Inc,ANIK,,0000898437,2014.0,Q4,2014-10-01,2014-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.54
Anika Therapeutics Inc,ANIK,,0000898437,2014.0,Q4,2014-10-01,2014-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,14700000.0
Anika Therapeutics Inc,ANIK,,0000898437,2014.0,Q4,2014-10-01,2014-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.52
Anika Therapeutics Inc,ANIK,,0000898437,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 16:06:15+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,15520000.0
Anika Therapeutics Inc,ANIK,,0000898437,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 16:06:15+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,15520000.0
Anika Therapeutics Inc,ANIK,,0000898437,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 16:06:15+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4313000.0
Anika Therapeutics Inc,ANIK,,0000898437,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 16:06:15+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4313000.0
Anika Therapeutics Inc,ANIK,,0000898437,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 16:06:15+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,11207000.0
Anika Therapeutics Inc,ANIK,,0000898437,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 16:06:15+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3605000.0
Anika Therapeutics Inc,ANIK,,0000898437,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 16:06:15+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2098000.0
Anika Therapeutics Inc,ANIK,,0000898437,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 16:06:15+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5703000.0
Anika Therapeutics Inc,ANIK,,0000898437,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 16:06:15+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,5504000.0
Anika Therapeutics Inc,ANIK,,0000898437,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 16:06:15+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,24000.0
Anika Therapeutics Inc,ANIK,,0000898437,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 16:06:15+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,24000.0
Anika Therapeutics Inc,ANIK,,0000898437,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 16:06:15+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,5528000.0
Anika Therapeutics Inc,ANIK,,0000898437,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 16:06:15+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,2012000.0
Anika Therapeutics Inc,ANIK,,0000898437,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 16:06:15+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3516000.0
Anika Therapeutics Inc,ANIK,,0000898437,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 16:06:15+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3516000.0
Anika Therapeutics Inc,ANIK,,0000898437,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 16:06:15+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3516000.0
Anika Therapeutics Inc,ANIK,,0000898437,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 16:06:15+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,14905000.0
Anika Therapeutics Inc,ANIK,,0000898437,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 16:06:15+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.24
Anika Therapeutics Inc,ANIK,,0000898437,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 16:06:15+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,15330000.0
Anika Therapeutics Inc,ANIK,,0000898437,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 16:06:15+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.23
Anika Therapeutics Inc,ANIK,,0000898437,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 16:06:15+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,14700000.0
Anika Therapeutics Inc,ANIK,,0000898437,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 16:06:15+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.24
Anika Therapeutics Inc,ANIK,,0000898437,2015.0,Q2,2015-04-01,2015-06-30,2015-08-04 16:23:45+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,22903561.0
Anika Therapeutics Inc,ANIK,,0000898437,2015.0,Q2,2015-04-01,2015-06-30,2015-08-04 16:23:45+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,22903561.0
Anika Therapeutics Inc,ANIK,,0000898437,2015.0,Q2,2015-04-01,2015-06-30,2015-08-04 16:23:45+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,5274059.0
Anika Therapeutics Inc,ANIK,,0000898437,2015.0,Q2,2015-04-01,2015-06-30,2015-08-04 16:23:45+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,5274059.0
Anika Therapeutics Inc,ANIK,,0000898437,2015.0,Q2,2015-04-01,2015-06-30,2015-08-04 16:23:45+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,17629502.0
Anika Therapeutics Inc,ANIK,,0000898437,2015.0,Q2,2015-04-01,2015-06-30,2015-08-04 16:23:45+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3388494.0
Anika Therapeutics Inc,ANIK,,0000898437,2015.0,Q2,2015-04-01,2015-06-30,2015-08-04 16:23:45+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1812320.0
Anika Therapeutics Inc,ANIK,,0000898437,2015.0,Q2,2015-04-01,2015-06-30,2015-08-04 16:23:45+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5200814.0
Anika Therapeutics Inc,ANIK,,0000898437,2015.0,Q2,2015-04-01,2015-06-30,2015-08-04 16:23:45+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,12428688.0
Anika Therapeutics Inc,ANIK,,0000898437,2015.0,Q2,2015-04-01,2015-06-30,2015-08-04 16:23:45+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,23907.0
Anika Therapeutics Inc,ANIK,,0000898437,2015.0,Q2,2015-04-01,2015-06-30,2015-08-04 16:23:45+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,23907.0
Anika Therapeutics Inc,ANIK,,0000898437,2015.0,Q2,2015-04-01,2015-06-30,2015-08-04 16:23:45+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,12452595.0
Anika Therapeutics Inc,ANIK,,0000898437,2015.0,Q2,2015-04-01,2015-06-30,2015-08-04 16:23:45+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,4633038.0
Anika Therapeutics Inc,ANIK,,0000898437,2015.0,Q2,2015-04-01,2015-06-30,2015-08-04 16:23:45+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,7819557.0
Anika Therapeutics Inc,ANIK,,0000898437,2015.0,Q2,2015-04-01,2015-06-30,2015-08-04 16:23:45+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,7819557.0
Anika Therapeutics Inc,ANIK,,0000898437,2015.0,Q2,2015-04-01,2015-06-30,2015-08-04 16:23:45+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,7819557.0
Anika Therapeutics Inc,ANIK,,0000898437,2015.0,Q2,2015-04-01,2015-06-30,2015-08-04 16:23:45+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,14961436.0
Anika Therapeutics Inc,ANIK,,0000898437,2015.0,Q2,2015-04-01,2015-06-30,2015-08-04 16:23:45+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.52
Anika Therapeutics Inc,ANIK,,0000898437,2015.0,Q2,2015-04-01,2015-06-30,2015-08-04 16:23:45+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,15335687.0
Anika Therapeutics Inc,ANIK,,0000898437,2015.0,Q2,2015-04-01,2015-06-30,2015-08-04 16:23:45+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.51
Anika Therapeutics Inc,ANIK,,0000898437,2015.0,Q2,2015-04-01,2015-06-30,2015-08-04 16:23:45+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,15000000.0
Anika Therapeutics Inc,ANIK,,0000898437,2015.0,Q2,2015-04-01,2015-06-30,2015-08-04 16:23:45+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.52
Anika Therapeutics Inc,ANIK,,0000898437,2015.0,Q3,2015-07-01,2015-09-30,2015-11-03 16:06:13+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,23681257.0
Anika Therapeutics Inc,ANIK,,0000898437,2015.0,Q3,2015-07-01,2015-09-30,2015-11-03 16:06:13+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,23681257.0
Anika Therapeutics Inc,ANIK,,0000898437,2015.0,Q3,2015-07-01,2015-09-30,2015-11-03 16:06:13+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,5175723.0
Anika Therapeutics Inc,ANIK,,0000898437,2015.0,Q3,2015-07-01,2015-09-30,2015-11-03 16:06:13+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,5175723.0
Anika Therapeutics Inc,ANIK,,0000898437,2015.0,Q3,2015-07-01,2015-09-30,2015-11-03 16:06:13+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,18505534.0
Anika Therapeutics Inc,ANIK,,0000898437,2015.0,Q3,2015-07-01,2015-09-30,2015-11-03 16:06:13+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3308731.0
Anika Therapeutics Inc,ANIK,,0000898437,2015.0,Q3,2015-07-01,2015-09-30,2015-11-03 16:06:13+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2061689.0
Anika Therapeutics Inc,ANIK,,0000898437,2015.0,Q3,2015-07-01,2015-09-30,2015-11-03 16:06:13+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5370420.0
Anika Therapeutics Inc,ANIK,,0000898437,2015.0,Q3,2015-07-01,2015-09-30,2015-11-03 16:06:13+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,13135114.0
Anika Therapeutics Inc,ANIK,,0000898437,2015.0,Q3,2015-07-01,2015-09-30,2015-11-03 16:06:13+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,33667.0
Anika Therapeutics Inc,ANIK,,0000898437,2015.0,Q3,2015-07-01,2015-09-30,2015-11-03 16:06:13+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,33667.0
Anika Therapeutics Inc,ANIK,,0000898437,2015.0,Q3,2015-07-01,2015-09-30,2015-11-03 16:06:13+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,13168781.0
Anika Therapeutics Inc,ANIK,,0000898437,2015.0,Q3,2015-07-01,2015-09-30,2015-11-03 16:06:13+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,4788916.0
Anika Therapeutics Inc,ANIK,,0000898437,2015.0,Q3,2015-07-01,2015-09-30,2015-11-03 16:06:13+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,8379865.0
Anika Therapeutics Inc,ANIK,,0000898437,2015.0,Q3,2015-07-01,2015-09-30,2015-11-03 16:06:13+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,8379865.0
Anika Therapeutics Inc,ANIK,,0000898437,2015.0,Q3,2015-07-01,2015-09-30,2015-11-03 16:06:13+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,8379865.0
Anika Therapeutics Inc,ANIK,,0000898437,2015.0,Q3,2015-07-01,2015-09-30,2015-11-03 16:06:13+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,14967322.0
Anika Therapeutics Inc,ANIK,,0000898437,2015.0,Q3,2015-07-01,2015-09-30,2015-11-03 16:06:13+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.56
Anika Therapeutics Inc,ANIK,,0000898437,2015.0,Q3,2015-07-01,2015-09-30,2015-11-03 16:06:13+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,15315808.0
Anika Therapeutics Inc,ANIK,,0000898437,2015.0,Q3,2015-07-01,2015-09-30,2015-11-03 16:06:13+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.55
Anika Therapeutics Inc,ANIK,,0000898437,2015.0,Q3,2015-07-01,2015-09-30,2015-11-03 16:06:13+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,15000000.0
Anika Therapeutics Inc,ANIK,,0000898437,2015.0,Q3,2015-07-01,2015-09-30,2015-11-03 16:06:13+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.56
Anika Therapeutics Inc,ANIK,,0000898437,2015.0,Q4,2015-10-01,2015-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,30894182.0
Anika Therapeutics Inc,ANIK,,0000898437,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,30894182.0
Anika Therapeutics Inc,ANIK,,0000898437,2015.0,Q4,2015-10-01,2015-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,6290218.0
Anika Therapeutics Inc,ANIK,,0000898437,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,6290218.0
Anika Therapeutics Inc,ANIK,,0000898437,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,24603964.0
Anika Therapeutics Inc,ANIK,,0000898437,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4522775.0
Anika Therapeutics Inc,ANIK,,0000898437,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3014991.0
Anika Therapeutics Inc,ANIK,,0000898437,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,7537766.0
Anika Therapeutics Inc,ANIK,,0000898437,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,17066198.0
Anika Therapeutics Inc,ANIK,,0000898437,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,38426.0
Anika Therapeutics Inc,ANIK,,0000898437,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,38426.0
Anika Therapeutics Inc,ANIK,,0000898437,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,17104624.0
Anika Therapeutics Inc,ANIK,,0000898437,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,6062046.0
Anika Therapeutics Inc,ANIK,,0000898437,2015.0,Q4,2015-10-01,2015-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,11042578.0
Anika Therapeutics Inc,ANIK,,0000898437,2015.0,Q4,2015-10-01,2015-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,11042578.0
Anika Therapeutics Inc,ANIK,,0000898437,2015.0,Q4,2015-10-01,2015-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,11042578.0
Anika Therapeutics Inc,ANIK,,0000898437,2015.0,Q4,2015-10-01,2015-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,14934000.0
Anika Therapeutics Inc,ANIK,,0000898437,2015.0,Q4,2015-10-01,2015-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.74
Anika Therapeutics Inc,ANIK,,0000898437,2015.0,Q4,2015-10-01,2015-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,15321000.0
Anika Therapeutics Inc,ANIK,,0000898437,2015.0,Q4,2015-10-01,2015-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.72
Anika Therapeutics Inc,ANIK,,0000898437,2015.0,Q4,2015-10-01,2015-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,14900000.0
Anika Therapeutics Inc,ANIK,,0000898437,2015.0,Q4,2015-10-01,2015-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.74
Anika Therapeutics Inc,ANIK,,0000898437,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:48:03+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,22283000.0
Anika Therapeutics Inc,ANIK,,0000898437,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:48:03+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,22283000.0
Anika Therapeutics Inc,ANIK,,0000898437,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:48:03+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,5425000.0
Anika Therapeutics Inc,ANIK,,0000898437,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:48:03+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,5425000.0
Anika Therapeutics Inc,ANIK,,0000898437,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:48:03+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,16858000.0
Anika Therapeutics Inc,ANIK,,0000898437,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:48:03+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3990000.0
Anika Therapeutics Inc,ANIK,,0000898437,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:48:03+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2159000.0
Anika Therapeutics Inc,ANIK,,0000898437,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:48:03+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6149000.0
Anika Therapeutics Inc,ANIK,,0000898437,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:48:03+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,10709000.0
Anika Therapeutics Inc,ANIK,,0000898437,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:48:03+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,72000.0
Anika Therapeutics Inc,ANIK,,0000898437,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:48:03+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,72000.0
Anika Therapeutics Inc,ANIK,,0000898437,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:48:03+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,10781000.0
Anika Therapeutics Inc,ANIK,,0000898437,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:48:03+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,3886000.0
Anika Therapeutics Inc,ANIK,,0000898437,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:48:03+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,6895000.0
Anika Therapeutics Inc,ANIK,,0000898437,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:48:03+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,6895000.0
Anika Therapeutics Inc,ANIK,,0000898437,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:48:03+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,6895000.0
Anika Therapeutics Inc,ANIK,,0000898437,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:48:03+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,14875000.0
Anika Therapeutics Inc,ANIK,,0000898437,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:48:03+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.46
Anika Therapeutics Inc,ANIK,,0000898437,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:48:03+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,15307000.0
Anika Therapeutics Inc,ANIK,,0000898437,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:48:03+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.45
Anika Therapeutics Inc,ANIK,,0000898437,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:48:03+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,15000000.0
Anika Therapeutics Inc,ANIK,,0000898437,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:48:03+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.46
Anika Therapeutics Inc,ANIK,,0000898437,2016.0,Q2,2016-04-01,2016-06-30,2017-07-28 16:06:09+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,26581000.0
Anika Therapeutics Inc,ANIK,,0000898437,2016.0,Q2,2016-04-01,2016-06-30,2017-07-28 16:06:09+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,26581000.0
Anika Therapeutics Inc,ANIK,,0000898437,2016.0,Q2,2016-04-01,2016-06-30,2017-07-28 16:06:09+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,6065000.0
Anika Therapeutics Inc,ANIK,,0000898437,2016.0,Q2,2016-04-01,2016-06-30,2017-07-28 16:06:09+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,6065000.0
Anika Therapeutics Inc,ANIK,,0000898437,2016.0,Q2,2016-04-01,2016-06-30,2017-07-28 16:06:09+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,20516000.0
Anika Therapeutics Inc,ANIK,,0000898437,2016.0,Q2,2016-04-01,2016-06-30,2017-07-28 16:06:09+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4255000.0
Anika Therapeutics Inc,ANIK,,0000898437,2016.0,Q2,2016-04-01,2016-06-30,2017-07-28 16:06:09+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2792000.0
Anika Therapeutics Inc,ANIK,,0000898437,2016.0,Q2,2016-04-01,2016-06-30,2017-07-28 16:06:09+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,7047000.0
Anika Therapeutics Inc,ANIK,,0000898437,2016.0,Q2,2016-04-01,2016-06-30,2017-07-28 16:06:09+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,13469000.0
Anika Therapeutics Inc,ANIK,,0000898437,2016.0,Q2,2016-04-01,2016-06-30,2017-07-28 16:06:09+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,49000.0
Anika Therapeutics Inc,ANIK,,0000898437,2016.0,Q2,2016-04-01,2016-06-30,2017-07-28 16:06:09+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,49000.0
Anika Therapeutics Inc,ANIK,,0000898437,2016.0,Q2,2016-04-01,2016-06-30,2017-07-28 16:06:09+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,13518000.0
Anika Therapeutics Inc,ANIK,,0000898437,2016.0,Q2,2016-04-01,2016-06-30,2017-07-28 16:06:09+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,4903000.0
Anika Therapeutics Inc,ANIK,,0000898437,2016.0,Q2,2016-04-01,2016-06-30,2017-07-28 16:06:09+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,8615000.0
Anika Therapeutics Inc,ANIK,,0000898437,2016.0,Q2,2016-04-01,2016-06-30,2017-07-28 16:06:09+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,8615000.0
Anika Therapeutics Inc,ANIK,,0000898437,2016.0,Q2,2016-04-01,2016-06-30,2017-07-28 16:06:09+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,8615000.0
Anika Therapeutics Inc,ANIK,,0000898437,2016.0,Q2,2016-04-01,2016-06-30,2017-07-28 16:06:09+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,14679000.0
Anika Therapeutics Inc,ANIK,,0000898437,2016.0,Q2,2016-04-01,2016-06-30,2017-07-28 16:06:09+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.59
Anika Therapeutics Inc,ANIK,,0000898437,2016.0,Q2,2016-04-01,2016-06-30,2017-07-28 16:06:09+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,15111000.0
Anika Therapeutics Inc,ANIK,,0000898437,2016.0,Q2,2016-04-01,2016-06-30,2017-07-28 16:06:09+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.57
Anika Therapeutics Inc,ANIK,,0000898437,2016.0,Q2,2016-04-01,2016-06-30,2017-07-28 16:06:09+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,14600000.0
Anika Therapeutics Inc,ANIK,,0000898437,2016.0,Q2,2016-04-01,2016-06-30,2017-07-28 16:06:09+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.59
Anika Therapeutics Inc,ANIK,,0000898437,2016.0,Q3,2016-07-01,2016-09-30,2017-10-27 16:59:09+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,25789000.0
Anika Therapeutics Inc,ANIK,,0000898437,2016.0,Q3,2016-07-01,2016-09-30,2017-10-27 16:59:09+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,25789000.0
Anika Therapeutics Inc,ANIK,,0000898437,2016.0,Q3,2016-07-01,2016-09-30,2017-10-27 16:59:09+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4998000.0
Anika Therapeutics Inc,ANIK,,0000898437,2016.0,Q3,2016-07-01,2016-09-30,2017-10-27 16:59:09+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4998000.0
Anika Therapeutics Inc,ANIK,,0000898437,2016.0,Q3,2016-07-01,2016-09-30,2017-10-27 16:59:09+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,20791000.0
Anika Therapeutics Inc,ANIK,,0000898437,2016.0,Q3,2016-07-01,2016-09-30,2017-10-27 16:59:09+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4280000.0
Anika Therapeutics Inc,ANIK,,0000898437,2016.0,Q3,2016-07-01,2016-09-30,2017-10-27 16:59:09+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2822000.0
Anika Therapeutics Inc,ANIK,,0000898437,2016.0,Q3,2016-07-01,2016-09-30,2017-10-27 16:59:09+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,7102000.0
Anika Therapeutics Inc,ANIK,,0000898437,2016.0,Q3,2016-07-01,2016-09-30,2017-10-27 16:59:09+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,13689000.0
Anika Therapeutics Inc,ANIK,,0000898437,2016.0,Q3,2016-07-01,2016-09-30,2017-10-27 16:59:09+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,93000.0
Anika Therapeutics Inc,ANIK,,0000898437,2016.0,Q3,2016-07-01,2016-09-30,2017-10-27 16:59:09+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,93000.0
Anika Therapeutics Inc,ANIK,,0000898437,2016.0,Q3,2016-07-01,2016-09-30,2017-10-27 16:59:09+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,13782000.0
Anika Therapeutics Inc,ANIK,,0000898437,2016.0,Q3,2016-07-01,2016-09-30,2017-10-27 16:59:09+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,4830000.0
Anika Therapeutics Inc,ANIK,,0000898437,2016.0,Q3,2016-07-01,2016-09-30,2017-10-27 16:59:09+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,8952000.0
Anika Therapeutics Inc,ANIK,,0000898437,2016.0,Q3,2016-07-01,2016-09-30,2017-10-27 16:59:09+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,8952000.0
Anika Therapeutics Inc,ANIK,,0000898437,2016.0,Q3,2016-07-01,2016-09-30,2017-10-27 16:59:09+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,8952000.0
Anika Therapeutics Inc,ANIK,,0000898437,2016.0,Q3,2016-07-01,2016-09-30,2017-10-27 16:59:09+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,14625000.0
Anika Therapeutics Inc,ANIK,,0000898437,2016.0,Q3,2016-07-01,2016-09-30,2017-10-27 16:59:09+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.61
Anika Therapeutics Inc,ANIK,,0000898437,2016.0,Q3,2016-07-01,2016-09-30,2017-10-27 16:59:09+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,15077000.0
Anika Therapeutics Inc,ANIK,,0000898437,2016.0,Q3,2016-07-01,2016-09-30,2017-10-27 16:59:09+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.59
Anika Therapeutics Inc,ANIK,,0000898437,2016.0,Q3,2016-07-01,2016-09-30,2017-10-27 16:59:09+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,14700000.0
Anika Therapeutics Inc,ANIK,,0000898437,2016.0,Q3,2016-07-01,2016-09-30,2017-10-27 16:59:09+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.61
Anika Therapeutics Inc,ANIK,,0000898437,2016.0,Q4,2016-10-01,2016-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,28726000.0
Anika Therapeutics Inc,ANIK,,0000898437,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,28726000.0
Anika Therapeutics Inc,ANIK,,0000898437,2016.0,Q4,2016-10-01,2016-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,7539000.0
Anika Therapeutics Inc,ANIK,,0000898437,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,7539000.0
Anika Therapeutics Inc,ANIK,,0000898437,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,21187000.0
Anika Therapeutics Inc,ANIK,,0000898437,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5488000.0
Anika Therapeutics Inc,ANIK,,0000898437,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2959000.0
Anika Therapeutics Inc,ANIK,,0000898437,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8447000.0
Anika Therapeutics Inc,ANIK,,0000898437,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,12740000.0
Anika Therapeutics Inc,ANIK,,0000898437,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,49000.0
Anika Therapeutics Inc,ANIK,,0000898437,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,49000.0
Anika Therapeutics Inc,ANIK,,0000898437,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,12789000.0
Anika Therapeutics Inc,ANIK,,0000898437,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,4704000.0
Anika Therapeutics Inc,ANIK,,0000898437,2016.0,Q4,2016-10-01,2016-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,8085000.0
Anika Therapeutics Inc,ANIK,,0000898437,2016.0,Q4,2016-10-01,2016-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,8085000.0
Anika Therapeutics Inc,ANIK,,0000898437,2016.0,Q4,2016-10-01,2016-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,8085000.0
Anika Therapeutics Inc,ANIK,,0000898437,2016.0,Q4,2016-10-01,2016-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,14682000.0
Anika Therapeutics Inc,ANIK,,0000898437,2016.0,Q4,2016-10-01,2016-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.56
Anika Therapeutics Inc,ANIK,,0000898437,2016.0,Q4,2016-10-01,2016-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,15116000.0
Anika Therapeutics Inc,ANIK,,0000898437,2016.0,Q4,2016-10-01,2016-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.54
Anika Therapeutics Inc,ANIK,,0000898437,2016.0,Q4,2016-10-01,2016-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,14700000.0
Anika Therapeutics Inc,ANIK,,0000898437,2016.0,Q4,2016-10-01,2016-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.56
Anika Therapeutics Inc,ANIK,,0000898437,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 14:00:09+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,23386000.0
Anika Therapeutics Inc,ANIK,,0000898437,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 14:00:09+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,23386000.0
Anika Therapeutics Inc,ANIK,,0000898437,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 14:00:09+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,6083000.0
Anika Therapeutics Inc,ANIK,,0000898437,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 14:00:09+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,6083000.0
Anika Therapeutics Inc,ANIK,,0000898437,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 14:00:09+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,17303000.0
Anika Therapeutics Inc,ANIK,,0000898437,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 14:00:09+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5067000.0
Anika Therapeutics Inc,ANIK,,0000898437,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 14:00:09+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4230000.0
Anika Therapeutics Inc,ANIK,,0000898437,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 14:00:09+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,9297000.0
Anika Therapeutics Inc,ANIK,,0000898437,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 14:00:09+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,8006000.0
Anika Therapeutics Inc,ANIK,,0000898437,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 14:00:09+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,58000.0
Anika Therapeutics Inc,ANIK,,0000898437,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 14:00:09+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,58000.0
Anika Therapeutics Inc,ANIK,,0000898437,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 14:00:09+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,8064000.0
Anika Therapeutics Inc,ANIK,,0000898437,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 14:00:09+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,2571000.0
Anika Therapeutics Inc,ANIK,,0000898437,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 14:00:09+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5493000.0
Anika Therapeutics Inc,ANIK,,0000898437,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 14:00:09+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,5493000.0
Anika Therapeutics Inc,ANIK,,0000898437,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 14:00:09+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,5493000.0
Anika Therapeutics Inc,ANIK,,0000898437,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 14:00:09+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,14576000.0
Anika Therapeutics Inc,ANIK,,0000898437,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 14:00:09+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.38
Anika Therapeutics Inc,ANIK,,0000898437,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 14:00:09+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,15043000.0
Anika Therapeutics Inc,ANIK,,0000898437,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 14:00:09+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.37
Anika Therapeutics Inc,ANIK,,0000898437,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 14:00:09+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,14500000.0
Anika Therapeutics Inc,ANIK,,0000898437,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 14:00:09+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.38
Anika Therapeutics Inc,ANIK,,0000898437,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 17:28:35+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,33462000.0
Anika Therapeutics Inc,ANIK,,0000898437,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 17:28:35+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,33462000.0
Anika Therapeutics Inc,ANIK,,0000898437,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 17:28:35+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,6315000.0
Anika Therapeutics Inc,ANIK,,0000898437,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 17:28:35+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,6315000.0
Anika Therapeutics Inc,ANIK,,0000898437,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 17:28:35+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,27147000.0
Anika Therapeutics Inc,ANIK,,0000898437,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 17:28:35+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4972000.0
Anika Therapeutics Inc,ANIK,,0000898437,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 17:28:35+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4449000.0
Anika Therapeutics Inc,ANIK,,0000898437,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 17:28:35+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,9421000.0
Anika Therapeutics Inc,ANIK,,0000898437,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 17:28:35+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,17726000.0
Anika Therapeutics Inc,ANIK,,0000898437,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 17:28:35+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,16000.0
Anika Therapeutics Inc,ANIK,,0000898437,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 17:28:35+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,16000.0
Anika Therapeutics Inc,ANIK,,0000898437,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 17:28:35+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,17742000.0
Anika Therapeutics Inc,ANIK,,0000898437,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 17:28:35+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,6373000.0
Anika Therapeutics Inc,ANIK,,0000898437,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 17:28:35+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,11369000.0
Anika Therapeutics Inc,ANIK,,0000898437,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 17:28:35+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,11369000.0
Anika Therapeutics Inc,ANIK,,0000898437,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 17:28:35+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,11369000.0
Anika Therapeutics Inc,ANIK,,0000898437,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 17:28:35+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,14588000.0
Anika Therapeutics Inc,ANIK,,0000898437,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 17:28:35+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.78
Anika Therapeutics Inc,ANIK,,0000898437,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 17:28:35+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,15044000.0
Anika Therapeutics Inc,ANIK,,0000898437,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 17:28:35+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.76
Anika Therapeutics Inc,ANIK,,0000898437,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 17:28:35+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,14600000.0
Anika Therapeutics Inc,ANIK,,0000898437,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 17:28:35+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.78
Anika Therapeutics Inc,ANIK,,0000898437,2017.0,Q3,2017-07-01,2017-09-30,2018-10-26 16:21:40+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,27184000.0
Anika Therapeutics Inc,ANIK,,0000898437,2017.0,Q3,2017-07-01,2017-09-30,2018-10-26 16:21:40+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,27184000.0
Anika Therapeutics Inc,ANIK,,0000898437,2017.0,Q3,2017-07-01,2017-09-30,2018-10-26 16:21:40+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,6250000.0
Anika Therapeutics Inc,ANIK,,0000898437,2017.0,Q3,2017-07-01,2017-09-30,2018-10-26 16:21:40+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,6250000.0
Anika Therapeutics Inc,ANIK,,0000898437,2017.0,Q3,2017-07-01,2017-09-30,2018-10-26 16:21:40+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,20934000.0
Anika Therapeutics Inc,ANIK,,0000898437,2017.0,Q3,2017-07-01,2017-09-30,2018-10-26 16:21:40+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4823000.0
Anika Therapeutics Inc,ANIK,,0000898437,2017.0,Q3,2017-07-01,2017-09-30,2018-10-26 16:21:40+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5842000.0
Anika Therapeutics Inc,ANIK,,0000898437,2017.0,Q3,2017-07-01,2017-09-30,2018-10-26 16:21:40+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,10665000.0
Anika Therapeutics Inc,ANIK,,0000898437,2017.0,Q3,2017-07-01,2017-09-30,2018-10-26 16:21:40+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,10269000.0
Anika Therapeutics Inc,ANIK,,0000898437,2017.0,Q3,2017-07-01,2017-09-30,2018-10-26 16:21:40+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,261000.0
Anika Therapeutics Inc,ANIK,,0000898437,2017.0,Q3,2017-07-01,2017-09-30,2018-10-26 16:21:40+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,261000.0
Anika Therapeutics Inc,ANIK,,0000898437,2017.0,Q3,2017-07-01,2017-09-30,2018-10-26 16:21:40+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,10530000.0
Anika Therapeutics Inc,ANIK,,0000898437,2017.0,Q3,2017-07-01,2017-09-30,2018-10-26 16:21:40+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,3643000.0
Anika Therapeutics Inc,ANIK,,0000898437,2017.0,Q3,2017-07-01,2017-09-30,2018-10-26 16:21:40+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,6887000.0
Anika Therapeutics Inc,ANIK,,0000898437,2017.0,Q3,2017-07-01,2017-09-30,2018-10-26 16:21:40+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,6887000.0
Anika Therapeutics Inc,ANIK,,0000898437,2017.0,Q3,2017-07-01,2017-09-30,2018-10-26 16:21:40+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,6887000.0
Anika Therapeutics Inc,ANIK,,0000898437,2017.0,Q3,2017-07-01,2017-09-30,2018-10-26 16:21:40+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,14579000.0
Anika Therapeutics Inc,ANIK,,0000898437,2017.0,Q3,2017-07-01,2017-09-30,2018-10-26 16:21:40+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.47
Anika Therapeutics Inc,ANIK,,0000898437,2017.0,Q3,2017-07-01,2017-09-30,2018-10-26 16:21:40+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,15115000.0
Anika Therapeutics Inc,ANIK,,0000898437,2017.0,Q3,2017-07-01,2017-09-30,2018-10-26 16:21:40+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.46
Anika Therapeutics Inc,ANIK,,0000898437,2017.0,Q3,2017-07-01,2017-09-30,2018-10-26 16:21:40+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,14700000.0
Anika Therapeutics Inc,ANIK,,0000898437,2017.0,Q3,2017-07-01,2017-09-30,2018-10-26 16:21:40+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.47
Anika Therapeutics Inc,ANIK,,0000898437,2017.0,Q4,2017-10-01,2017-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,29388000.0
Anika Therapeutics Inc,ANIK,,0000898437,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,29388000.0
Anika Therapeutics Inc,ANIK,,0000898437,2017.0,Q4,2017-10-01,2017-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,8716000.0
Anika Therapeutics Inc,ANIK,,0000898437,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,8716000.0
Anika Therapeutics Inc,ANIK,,0000898437,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,20672000.0
Anika Therapeutics Inc,ANIK,,0000898437,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6678000.0
Anika Therapeutics Inc,ANIK,,0000898437,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4266000.0
Anika Therapeutics Inc,ANIK,,0000898437,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,10944000.0
Anika Therapeutics Inc,ANIK,,0000898437,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,9728000.0
Anika Therapeutics Inc,ANIK,,0000898437,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,138000.0
Anika Therapeutics Inc,ANIK,,0000898437,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,138000.0
Anika Therapeutics Inc,ANIK,,0000898437,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,9866000.0
Anika Therapeutics Inc,ANIK,,0000898437,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1799000.0
Anika Therapeutics Inc,ANIK,,0000898437,2017.0,Q4,2017-10-01,2017-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,8067000.0
Anika Therapeutics Inc,ANIK,,0000898437,2017.0,Q4,2017-10-01,2017-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,8067000.0
Anika Therapeutics Inc,ANIK,,0000898437,2017.0,Q4,2017-10-01,2017-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,8067000.0
Anika Therapeutics Inc,ANIK,,0000898437,2017.0,Q4,2017-10-01,2017-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,14575000.0
Anika Therapeutics Inc,ANIK,,0000898437,2017.0,Q4,2017-10-01,2017-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.55
Anika Therapeutics Inc,ANIK,,0000898437,2017.0,Q4,2017-10-01,2017-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,15068000.0
Anika Therapeutics Inc,ANIK,,0000898437,2017.0,Q4,2017-10-01,2017-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.52
Anika Therapeutics Inc,ANIK,,0000898437,2017.0,Q4,2017-10-01,2017-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,14600000.0
Anika Therapeutics Inc,ANIK,,0000898437,2017.0,Q4,2017-10-01,2017-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.55
Anika Therapeutics Inc,ANIK,,0000898437,2018.0,Q1,2018-01-01,2018-03-31,2019-05-03 19:05:34+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,21264000.0
Anika Therapeutics Inc,ANIK,,0000898437,2018.0,Q1,2018-01-01,2018-03-31,2019-05-03 19:05:34+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,21264000.0
Anika Therapeutics Inc,ANIK,,0000898437,2018.0,Q1,2018-01-01,2018-03-31,2019-05-03 19:05:34+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,7845000.0
Anika Therapeutics Inc,ANIK,,0000898437,2018.0,Q1,2018-01-01,2018-03-31,2019-05-03 19:05:34+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,7845000.0
Anika Therapeutics Inc,ANIK,,0000898437,2018.0,Q1,2018-01-01,2018-03-31,2019-05-03 19:05:34+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,13419000.0
Anika Therapeutics Inc,ANIK,,0000898437,2018.0,Q1,2018-01-01,2018-03-31,2019-05-03 19:05:34+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,16090000.0
Anika Therapeutics Inc,ANIK,,0000898437,2018.0,Q1,2018-01-01,2018-03-31,2019-05-03 19:05:34+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5161000.0
Anika Therapeutics Inc,ANIK,,0000898437,2018.0,Q1,2018-01-01,2018-03-31,2019-05-03 19:05:34+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,21251000.0
Anika Therapeutics Inc,ANIK,,0000898437,2018.0,Q1,2018-01-01,2018-03-31,2019-05-03 19:05:34+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-7832000.0
Anika Therapeutics Inc,ANIK,,0000898437,2018.0,Q1,2018-01-01,2018-03-31,2019-05-03 19:05:34+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,95000.0
Anika Therapeutics Inc,ANIK,,0000898437,2018.0,Q1,2018-01-01,2018-03-31,2019-05-03 19:05:34+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,95000.0
Anika Therapeutics Inc,ANIK,,0000898437,2018.0,Q1,2018-01-01,2018-03-31,2019-05-03 19:05:34+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-7737000.0
Anika Therapeutics Inc,ANIK,,0000898437,2018.0,Q1,2018-01-01,2018-03-31,2019-05-03 19:05:34+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-1051000.0
Anika Therapeutics Inc,ANIK,,0000898437,2018.0,Q1,2018-01-01,2018-03-31,2019-05-03 19:05:34+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6686000.0
Anika Therapeutics Inc,ANIK,,0000898437,2018.0,Q1,2018-01-01,2018-03-31,2019-05-03 19:05:34+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6686000.0
Anika Therapeutics Inc,ANIK,,0000898437,2018.0,Q1,2018-01-01,2018-03-31,2019-05-03 19:05:34+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-6686000.0
Anika Therapeutics Inc,ANIK,,0000898437,2018.0,Q1,2018-01-01,2018-03-31,2019-05-03 19:05:34+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,14679000.0
Anika Therapeutics Inc,ANIK,,0000898437,2018.0,Q1,2018-01-01,2018-03-31,2019-05-03 19:05:34+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.46
Anika Therapeutics Inc,ANIK,,0000898437,2018.0,Q1,2018-01-01,2018-03-31,2019-05-03 19:05:34+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,14679000.0
Anika Therapeutics Inc,ANIK,,0000898437,2018.0,Q1,2018-01-01,2018-03-31,2019-05-03 19:05:34+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.46
Anika Therapeutics Inc,ANIK,,0000898437,2018.0,Q1,2018-01-01,2018-03-31,2019-05-03 19:05:34+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,14500000.0
Anika Therapeutics Inc,ANIK,,0000898437,2018.0,Q1,2018-01-01,2018-03-31,2019-05-03 19:05:34+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.46
Anika Therapeutics Inc,ANIK,,0000898437,2018.0,Q2,2018-04-01,2018-06-30,2019-07-26 17:00:25+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,30548000.0
Anika Therapeutics Inc,ANIK,,0000898437,2018.0,Q2,2018-04-01,2018-06-30,2019-07-26 17:00:25+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,30548000.0
Anika Therapeutics Inc,ANIK,,0000898437,2018.0,Q2,2018-04-01,2018-06-30,2019-07-26 17:00:25+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,8152000.0
Anika Therapeutics Inc,ANIK,,0000898437,2018.0,Q2,2018-04-01,2018-06-30,2019-07-26 17:00:25+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,8152000.0
Anika Therapeutics Inc,ANIK,,0000898437,2018.0,Q2,2018-04-01,2018-06-30,2019-07-26 17:00:25+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,22396000.0
Anika Therapeutics Inc,ANIK,,0000898437,2018.0,Q2,2018-04-01,2018-06-30,2019-07-26 17:00:25+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6417000.0
Anika Therapeutics Inc,ANIK,,0000898437,2018.0,Q2,2018-04-01,2018-06-30,2019-07-26 17:00:25+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4733000.0
Anika Therapeutics Inc,ANIK,,0000898437,2018.0,Q2,2018-04-01,2018-06-30,2019-07-26 17:00:25+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,11150000.0
Anika Therapeutics Inc,ANIK,,0000898437,2018.0,Q2,2018-04-01,2018-06-30,2019-07-26 17:00:25+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,11246000.0
Anika Therapeutics Inc,ANIK,,0000898437,2018.0,Q2,2018-04-01,2018-06-30,2019-07-26 17:00:25+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,290000.0
Anika Therapeutics Inc,ANIK,,0000898437,2018.0,Q2,2018-04-01,2018-06-30,2019-07-26 17:00:25+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,290000.0
Anika Therapeutics Inc,ANIK,,0000898437,2018.0,Q2,2018-04-01,2018-06-30,2019-07-26 17:00:25+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,11536000.0
Anika Therapeutics Inc,ANIK,,0000898437,2018.0,Q2,2018-04-01,2018-06-30,2019-07-26 17:00:25+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1444000.0
Anika Therapeutics Inc,ANIK,,0000898437,2018.0,Q2,2018-04-01,2018-06-30,2019-07-26 17:00:25+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,10092000.0
Anika Therapeutics Inc,ANIK,,0000898437,2018.0,Q2,2018-04-01,2018-06-30,2019-07-26 17:00:25+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,10092000.0
Anika Therapeutics Inc,ANIK,,0000898437,2018.0,Q2,2018-04-01,2018-06-30,2019-07-26 17:00:25+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,10092000.0
Anika Therapeutics Inc,ANIK,,0000898437,2018.0,Q2,2018-04-01,2018-06-30,2019-07-26 17:00:25+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,14652000.0
Anika Therapeutics Inc,ANIK,,0000898437,2018.0,Q2,2018-04-01,2018-06-30,2019-07-26 17:00:25+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.69
Anika Therapeutics Inc,ANIK,,0000898437,2018.0,Q2,2018-04-01,2018-06-30,2019-07-26 17:00:25+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,14915000.0
Anika Therapeutics Inc,ANIK,,0000898437,2018.0,Q2,2018-04-01,2018-06-30,2019-07-26 17:00:25+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.68
Anika Therapeutics Inc,ANIK,,0000898437,2018.0,Q2,2018-04-01,2018-06-30,2019-07-26 17:00:25+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,14600000.0
Anika Therapeutics Inc,ANIK,,0000898437,2018.0,Q2,2018-04-01,2018-06-30,2019-07-26 17:00:25+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.69
Anika Therapeutics Inc,ANIK,,0000898437,2018.0,Q3,2018-07-01,2018-09-30,2019-10-28 17:20:32+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,26787000.0
Anika Therapeutics Inc,ANIK,,0000898437,2018.0,Q3,2018-07-01,2018-09-30,2019-10-28 17:20:32+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,26787000.0
Anika Therapeutics Inc,ANIK,,0000898437,2018.0,Q3,2018-07-01,2018-09-30,2019-10-28 17:20:32+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,8282000.0
Anika Therapeutics Inc,ANIK,,0000898437,2018.0,Q3,2018-07-01,2018-09-30,2019-10-28 17:20:32+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,8282000.0
Anika Therapeutics Inc,ANIK,,0000898437,2018.0,Q3,2018-07-01,2018-09-30,2019-10-28 17:20:32+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,18505000.0
Anika Therapeutics Inc,ANIK,,0000898437,2018.0,Q3,2018-07-01,2018-09-30,2019-10-28 17:20:32+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5700000.0
Anika Therapeutics Inc,ANIK,,0000898437,2018.0,Q3,2018-07-01,2018-09-30,2019-10-28 17:20:32+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4232000.0
Anika Therapeutics Inc,ANIK,,0000898437,2018.0,Q3,2018-07-01,2018-09-30,2019-10-28 17:20:32+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,9932000.0
Anika Therapeutics Inc,ANIK,,0000898437,2018.0,Q3,2018-07-01,2018-09-30,2019-10-28 17:20:32+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,8573000.0
Anika Therapeutics Inc,ANIK,,0000898437,2018.0,Q3,2018-07-01,2018-09-30,2019-10-28 17:20:32+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,522000.0
Anika Therapeutics Inc,ANIK,,0000898437,2018.0,Q3,2018-07-01,2018-09-30,2019-10-28 17:20:32+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,522000.0
Anika Therapeutics Inc,ANIK,,0000898437,2018.0,Q3,2018-07-01,2018-09-30,2019-10-28 17:20:32+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,9095000.0
Anika Therapeutics Inc,ANIK,,0000898437,2018.0,Q3,2018-07-01,2018-09-30,2019-10-28 17:20:32+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1496000.0
Anika Therapeutics Inc,ANIK,,0000898437,2018.0,Q3,2018-07-01,2018-09-30,2019-10-28 17:20:32+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,7599000.0
Anika Therapeutics Inc,ANIK,,0000898437,2018.0,Q3,2018-07-01,2018-09-30,2019-10-28 17:20:32+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,7599000.0
Anika Therapeutics Inc,ANIK,,0000898437,2018.0,Q3,2018-07-01,2018-09-30,2019-10-28 17:20:32+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,7599000.0
Anika Therapeutics Inc,ANIK,,0000898437,2018.0,Q3,2018-07-01,2018-09-30,2019-10-28 17:20:32+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,14237000.0
Anika Therapeutics Inc,ANIK,,0000898437,2018.0,Q3,2018-07-01,2018-09-30,2019-10-28 17:20:32+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.53
Anika Therapeutics Inc,ANIK,,0000898437,2018.0,Q3,2018-07-01,2018-09-30,2019-10-28 17:20:32+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,14377000.0
Anika Therapeutics Inc,ANIK,,0000898437,2018.0,Q3,2018-07-01,2018-09-30,2019-10-28 17:20:32+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.53
Anika Therapeutics Inc,ANIK,,0000898437,2018.0,Q3,2018-07-01,2018-09-30,2019-10-28 17:20:32+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,14300000.0
Anika Therapeutics Inc,ANIK,,0000898437,2018.0,Q3,2018-07-01,2018-09-30,2019-10-28 17:20:32+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.53
Anika Therapeutics Inc,ANIK,,0000898437,2018.0,Q4,2018-10-01,2018-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,26956000.0
Anika Therapeutics Inc,ANIK,,0000898437,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,26956000.0
Anika Therapeutics Inc,ANIK,,0000898437,2018.0,Q4,2018-10-01,2018-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,7001000.0
Anika Therapeutics Inc,ANIK,,0000898437,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,7001000.0
Anika Therapeutics Inc,ANIK,,0000898437,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,19955000.0
Anika Therapeutics Inc,ANIK,,0000898437,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6129000.0
Anika Therapeutics Inc,ANIK,,0000898437,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4064000.0
Anika Therapeutics Inc,ANIK,,0000898437,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,10193000.0
Anika Therapeutics Inc,ANIK,,0000898437,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,9762000.0
Anika Therapeutics Inc,ANIK,,0000898437,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,551000.0
Anika Therapeutics Inc,ANIK,,0000898437,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,551000.0
Anika Therapeutics Inc,ANIK,,0000898437,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,10313000.0
Anika Therapeutics Inc,ANIK,,0000898437,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,2596000.0
Anika Therapeutics Inc,ANIK,,0000898437,2018.0,Q4,2018-10-01,2018-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,7717000.0
Anika Therapeutics Inc,ANIK,,0000898437,2018.0,Q4,2018-10-01,2018-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,7717000.0
Anika Therapeutics Inc,ANIK,,0000898437,2018.0,Q4,2018-10-01,2018-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,7717000.0
Anika Therapeutics Inc,ANIK,,0000898437,2018.0,Q4,2018-10-01,2018-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,14442000.0
Anika Therapeutics Inc,ANIK,,0000898437,2018.0,Q4,2018-10-01,2018-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.54
Anika Therapeutics Inc,ANIK,,0000898437,2018.0,Q4,2018-10-01,2018-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,14689000.0
Anika Therapeutics Inc,ANIK,,0000898437,2018.0,Q4,2018-10-01,2018-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.52
Anika Therapeutics Inc,ANIK,,0000898437,2018.0,Q4,2018-10-01,2018-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,14400000.0
Anika Therapeutics Inc,ANIK,,0000898437,2018.0,Q4,2018-10-01,2018-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.54
Anika Therapeutics Inc,ANIK,,0000898437,2019.0,Q1,2019-01-01,2019-03-31,2020-05-22 16:58:00+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,24723000.0
Anika Therapeutics Inc,ANIK,,0000898437,2019.0,Q1,2019-01-01,2019-03-31,2020-05-22 16:58:00+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,24723000.0
Anika Therapeutics Inc,ANIK,,0000898437,2019.0,Q1,2019-01-01,2019-03-31,2020-05-22 16:58:00+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,7311000.0
Anika Therapeutics Inc,ANIK,,0000898437,2019.0,Q1,2019-01-01,2019-03-31,2020-05-22 16:58:00+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,7311000.0
Anika Therapeutics Inc,ANIK,,0000898437,2019.0,Q1,2019-01-01,2019-03-31,2020-05-22 16:58:00+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,17412000.0
Anika Therapeutics Inc,ANIK,,0000898437,2019.0,Q1,2019-01-01,2019-03-31,2020-05-22 16:58:00+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7672000.0
Anika Therapeutics Inc,ANIK,,0000898437,2019.0,Q1,2019-01-01,2019-03-31,2020-05-22 16:58:00+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4258000.0
Anika Therapeutics Inc,ANIK,,0000898437,2019.0,Q1,2019-01-01,2019-03-31,2020-05-22 16:58:00+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,0.0
Anika Therapeutics Inc,ANIK,,0000898437,2019.0,Q1,2019-01-01,2019-03-31,2020-05-22 16:58:00+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,0.0
Anika Therapeutics Inc,ANIK,,0000898437,2019.0,Q1,2019-01-01,2019-03-31,2020-05-22 16:58:00+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,11930000.0
Anika Therapeutics Inc,ANIK,,0000898437,2019.0,Q1,2019-01-01,2019-03-31,2020-05-22 16:58:00+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,5482000.0
Anika Therapeutics Inc,ANIK,,0000898437,2019.0,Q1,2019-01-01,2019-03-31,2020-05-22 16:58:00+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,498000.0
Anika Therapeutics Inc,ANIK,,0000898437,2019.0,Q1,2019-01-01,2019-03-31,2020-05-22 16:58:00+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,498000.0
Anika Therapeutics Inc,ANIK,,0000898437,2019.0,Q1,2019-01-01,2019-03-31,2020-05-22 16:58:00+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,5980000.0
Anika Therapeutics Inc,ANIK,,0000898437,2019.0,Q1,2019-01-01,2019-03-31,2020-05-22 16:58:00+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1473000.0
Anika Therapeutics Inc,ANIK,,0000898437,2019.0,Q1,2019-01-01,2019-03-31,2020-05-22 16:58:00+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4507000.0
Anika Therapeutics Inc,ANIK,,0000898437,2019.0,Q1,2019-01-01,2019-03-31,2020-05-22 16:58:00+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4507000.0
Anika Therapeutics Inc,ANIK,,0000898437,2019.0,Q1,2019-01-01,2019-03-31,2020-05-22 16:58:00+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,4507000.0
Anika Therapeutics Inc,ANIK,,0000898437,2019.0,Q1,2019-01-01,2019-03-31,2020-05-22 16:58:00+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,14185000.0
Anika Therapeutics Inc,ANIK,,0000898437,2019.0,Q1,2019-01-01,2019-03-31,2020-05-22 16:58:00+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.32
Anika Therapeutics Inc,ANIK,,0000898437,2019.0,Q1,2019-01-01,2019-03-31,2020-05-22 16:58:00+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,14314000.0
Anika Therapeutics Inc,ANIK,,0000898437,2019.0,Q1,2019-01-01,2019-03-31,2020-05-22 16:58:00+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.31
Anika Therapeutics Inc,ANIK,,0000898437,2019.0,Q1,2019-01-01,2019-03-31,2020-05-22 16:58:00+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,14100000.0
Anika Therapeutics Inc,ANIK,,0000898437,2019.0,Q1,2019-01-01,2019-03-31,2020-05-22 16:58:00+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.32
Anika Therapeutics Inc,ANIK,,0000898437,2019.0,Q2,2019-04-01,2019-06-30,2019-07-26 17:00:25+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,30418000.0
Anika Therapeutics Inc,ANIK,,0000898437,2019.0,Q2,2019-04-01,2019-06-30,2019-07-26 17:00:25+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,30418000.0
Anika Therapeutics Inc,ANIK,,0000898437,2019.0,Q2,2019-04-01,2019-06-30,2019-07-26 17:00:25+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,6836000.0
Anika Therapeutics Inc,ANIK,,0000898437,2019.0,Q2,2019-04-01,2019-06-30,2019-07-26 17:00:25+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,6836000.0
Anika Therapeutics Inc,ANIK,,0000898437,2019.0,Q2,2019-04-01,2019-06-30,2019-07-26 17:00:25+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,23582000.0
Anika Therapeutics Inc,ANIK,,0000898437,2019.0,Q2,2019-04-01,2019-06-30,2019-07-26 17:00:25+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7502000.0
Anika Therapeutics Inc,ANIK,,0000898437,2019.0,Q2,2019-04-01,2019-06-30,2019-07-26 17:00:25+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4165000.0
Anika Therapeutics Inc,ANIK,,0000898437,2019.0,Q2,2019-04-01,2019-06-30,2019-07-26 17:00:25+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,11667000.0
Anika Therapeutics Inc,ANIK,,0000898437,2019.0,Q2,2019-04-01,2019-06-30,2019-07-26 17:00:25+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,11915000.0
Anika Therapeutics Inc,ANIK,,0000898437,2019.0,Q2,2019-04-01,2019-06-30,2019-07-26 17:00:25+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,533000.0
Anika Therapeutics Inc,ANIK,,0000898437,2019.0,Q2,2019-04-01,2019-06-30,2019-07-26 17:00:25+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,533000.0
Anika Therapeutics Inc,ANIK,,0000898437,2019.0,Q2,2019-04-01,2019-06-30,2019-07-26 17:00:25+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,12448000.0
Anika Therapeutics Inc,ANIK,,0000898437,2019.0,Q2,2019-04-01,2019-06-30,2019-07-26 17:00:25+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,3013000.0
Anika Therapeutics Inc,ANIK,,0000898437,2019.0,Q2,2019-04-01,2019-06-30,2019-07-26 17:00:25+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,9435000.0
Anika Therapeutics Inc,ANIK,,0000898437,2019.0,Q2,2019-04-01,2019-06-30,2019-07-26 17:00:25+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,9435000.0
Anika Therapeutics Inc,ANIK,,0000898437,2019.0,Q2,2019-04-01,2019-06-30,2019-07-26 17:00:25+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,9435000.0
Anika Therapeutics Inc,ANIK,,0000898437,2019.0,Q2,2019-04-01,2019-06-30,2019-07-26 17:00:25+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,13916000.0
Anika Therapeutics Inc,ANIK,,0000898437,2019.0,Q2,2019-04-01,2019-06-30,2019-07-26 17:00:25+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.68
Anika Therapeutics Inc,ANIK,,0000898437,2019.0,Q2,2019-04-01,2019-06-30,2019-07-26 17:00:25+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,14088000.0
Anika Therapeutics Inc,ANIK,,0000898437,2019.0,Q2,2019-04-01,2019-06-30,2019-07-26 17:00:25+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.67
Anika Therapeutics Inc,ANIK,,0000898437,2019.0,Q2,2019-04-01,2019-06-30,2019-07-26 17:00:25+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,13900000.0
Anika Therapeutics Inc,ANIK,,0000898437,2019.0,Q2,2019-04-01,2019-06-30,2019-07-26 17:00:25+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.68
Anika Therapeutics Inc,ANIK,,0000898437,2019.0,Q3,2019-07-01,2019-09-30,2019-10-28 17:20:32+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,29697000.0
Anika Therapeutics Inc,ANIK,,0000898437,2019.0,Q3,2019-07-01,2019-09-30,2019-10-28 17:20:32+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,29697000.0
Anika Therapeutics Inc,ANIK,,0000898437,2019.0,Q3,2019-07-01,2019-09-30,2019-10-28 17:20:32+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,5951000.0
Anika Therapeutics Inc,ANIK,,0000898437,2019.0,Q3,2019-07-01,2019-09-30,2019-10-28 17:20:32+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,5951000.0
Anika Therapeutics Inc,ANIK,,0000898437,2019.0,Q3,2019-07-01,2019-09-30,2019-10-28 17:20:32+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,23746000.0
Anika Therapeutics Inc,ANIK,,0000898437,2019.0,Q3,2019-07-01,2019-09-30,2019-10-28 17:20:32+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7539000.0
Anika Therapeutics Inc,ANIK,,0000898437,2019.0,Q3,2019-07-01,2019-09-30,2019-10-28 17:20:32+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4158000.0
Anika Therapeutics Inc,ANIK,,0000898437,2019.0,Q3,2019-07-01,2019-09-30,2019-10-28 17:20:32+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,11697000.0
Anika Therapeutics Inc,ANIK,,0000898437,2019.0,Q3,2019-07-01,2019-09-30,2019-10-28 17:20:32+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,12049000.0
Anika Therapeutics Inc,ANIK,,0000898437,2019.0,Q3,2019-07-01,2019-09-30,2019-10-28 17:20:32+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,482000.0
Anika Therapeutics Inc,ANIK,,0000898437,2019.0,Q3,2019-07-01,2019-09-30,2019-10-28 17:20:32+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,482000.0
Anika Therapeutics Inc,ANIK,,0000898437,2019.0,Q3,2019-07-01,2019-09-30,2019-10-28 17:20:32+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,12531000.0
Anika Therapeutics Inc,ANIK,,0000898437,2019.0,Q3,2019-07-01,2019-09-30,2019-10-28 17:20:32+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,3331000.0
Anika Therapeutics Inc,ANIK,,0000898437,2019.0,Q3,2019-07-01,2019-09-30,2019-10-28 17:20:32+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,9200000.0
Anika Therapeutics Inc,ANIK,,0000898437,2019.0,Q3,2019-07-01,2019-09-30,2019-10-28 17:20:32+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,9200000.0
Anika Therapeutics Inc,ANIK,,0000898437,2019.0,Q3,2019-07-01,2019-09-30,2019-10-28 17:20:32+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,9200000.0
Anika Therapeutics Inc,ANIK,,0000898437,2019.0,Q3,2019-07-01,2019-09-30,2019-10-28 17:20:32+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,14070000.0
Anika Therapeutics Inc,ANIK,,0000898437,2019.0,Q3,2019-07-01,2019-09-30,2019-10-28 17:20:32+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.65
Anika Therapeutics Inc,ANIK,,0000898437,2019.0,Q3,2019-07-01,2019-09-30,2019-10-28 17:20:32+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,14387000.0
Anika Therapeutics Inc,ANIK,,0000898437,2019.0,Q3,2019-07-01,2019-09-30,2019-10-28 17:20:32+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.64
Anika Therapeutics Inc,ANIK,,0000898437,2019.0,Q3,2019-07-01,2019-09-30,2019-10-28 17:20:32+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,14200000.0
Anika Therapeutics Inc,ANIK,,0000898437,2019.0,Q3,2019-07-01,2019-09-30,2019-10-28 17:20:32+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.65
Anika Therapeutics Inc,ANIK,,0000898437,2019.0,Q4,2019-10-01,2019-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,29772000.0
Anika Therapeutics Inc,ANIK,,0000898437,2019.0,Q4,2019-10-01,2019-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,29772000.0
Anika Therapeutics Inc,ANIK,,0000898437,2019.0,Q4,2019-10-01,2019-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,8649000.0
Anika Therapeutics Inc,ANIK,,0000898437,2019.0,Q4,2019-10-01,2019-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,8649000.0
Anika Therapeutics Inc,ANIK,,0000898437,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,21123000.0
Anika Therapeutics Inc,ANIK,,0000898437,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,12237000.0
Anika Therapeutics Inc,ANIK,,0000898437,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4084000.0
Anika Therapeutics Inc,ANIK,,0000898437,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,16321000.0
Anika Therapeutics Inc,ANIK,,0000898437,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,4802000.0
Anika Therapeutics Inc,ANIK,,0000898437,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,360000.0
Anika Therapeutics Inc,ANIK,,0000898437,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,360000.0
Anika Therapeutics Inc,ANIK,,0000898437,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,5162000.0
Anika Therapeutics Inc,ANIK,,0000898437,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1111000.0
Anika Therapeutics Inc,ANIK,,0000898437,2019.0,Q4,2019-10-01,2019-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4051000.0
Anika Therapeutics Inc,ANIK,,0000898437,2019.0,Q4,2019-10-01,2019-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4051000.0
Anika Therapeutics Inc,ANIK,,0000898437,2019.0,Q4,2019-10-01,2019-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,4051000.0
Anika Therapeutics Inc,ANIK,,0000898437,2019.0,Q4,2019-10-01,2019-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,14121000.0
Anika Therapeutics Inc,ANIK,,0000898437,2019.0,Q4,2019-10-01,2019-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.28
Anika Therapeutics Inc,ANIK,,0000898437,2019.0,Q4,2019-10-01,2019-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,14374000.0
Anika Therapeutics Inc,ANIK,,0000898437,2019.0,Q4,2019-10-01,2019-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.27
Anika Therapeutics Inc,ANIK,,0000898437,2019.0,Q4,2019-10-01,2019-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,14100000.0
Anika Therapeutics Inc,ANIK,,0000898437,2019.0,Q4,2019-10-01,2019-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.28
